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ABSTRACT 
IMPROVING CARDIOVASCULAR STENT DESIGN USING PATIENT-
SPECIFIC MODELS AND SHAPE OPTIMIZATION 
Timothy J. Gundert 
Marquette University, 2011 
Stent geometry influences local hemodynamic alterations (i.e. the forces moving 
blood through the cardiovascular system) associated with adverse clinical outcomes. 
Computational fluid dynamics (CFD) is frequently used to quantify stent-induced 
hemodynamic disturbances, but previous CFD studies have relied on simplified device or 
vascular representations. Additionally, efforts to minimize stent-induced hemodynamic 
disturbances using CFD models often only compare a small number of possible stent 
geometries. This thesis describes methods for modeling commercial stents in patient-
specific vessels along with computational techniques for determining optimal stent 
geometries that address the limitations of previous studies. 
An efficient and robust method was developed for virtually implanting stent 
models into patient-specific vascular geometries derived from medical imaging data. 
Models of commercial stent designs were parameterized to allow easy control over 
design features. Stent models were then virtually implanted into vessel geometries using 
a series of Boolean operations. This approach allowed stented vessel models to be 
automatically regenerated for rapid analysis of the contribution of design features to 
resulting hemodynamic alterations. The applicability of the method was demonstrated 
with patient-specific models of a stented coronary artery bifurcation and basilar trunk 
aneurysm to reveal how it can be used to investigate differences in hemodynamic 
performance in complex vascular beds for a variety of clinical scenarios. 
To identify hemodynamically optimal stents designs, a computational framework 
was constructed to couple CFD with a derivative-free optimization algorithm. The 
optimization algorithm was fully-automated such that solid model construction, mesh 
generation, CFD simulation and time-averaged wall shear stress (TAWSS) quantification 
did not require user intervention. The method was applied to determine the optimal 
number of circumferentially repeating stent cells (NC) for a slotted-tube stents and various 
commercial stents. Optimal stent designs were defined as those minimizing the area of 
low TAWSS. It was determined the optimal value of NC is dependent on the intrastrut 
angle with respect to the primary flow direction. Additionally, the geometries of current 
commercial stents were found to generally incorporate a greater NC than is 
hemodynamically optimal. 
 The application of the virtual stent implantation and optimization methods may 
lead to stents with superior hemodynamic performance and the potential for improved 
clinical outcomes. Future in vivo studies are needed to validate the findings of the 
computational results obtained from the methods developed in this thesis.
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Chapter 1 
  
Background and Specific Aims 
1.1 Stents for the treatment of cardiovascular disease 
 Cardiovascular stents are commonly used as vessel scaffolding to alleviate an 
arterial narrowing or stenosis and restore blood flow to the distal vasculature. Since their 
inception in the mid 1980s, stents have gained popularity in the medical community 
because they allow diseased vessels to be treated using minimally invasive surgical 
techniques thereby reducing the trauma, cost and many complications associated with 
traditional surgery. Though stents have primarily been used to treat stenosis within 
coronary arteries, they have also been adopted for treating peripheral arteries, such as the 
carotid, renal and femoral arteries [20, 99].  
In addition to being used as vessel scaffolding, stents have recently been used as 
flow diversion devices. When used as flow diverting devices, stents are placed across 
aneurysms with the goal of occluding blood flow to the aneurysm and preventing 
potential rupture. Not to be confused with stent-grafts (fabric covered stents), flow 
diverting stents are not covered and rely on low porosity designs to alter blood flow. To 
date these devices have most commonly been used to treat intracranial aneurysms [22]. 
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Despite widespread use and several decades of research, the success of 
cardiovascular stents has been limited in some cases by adverse clinical outcomes. In-
stent restenosis, or a re-narrowing of a previously treated vessel due to excessive tissue 
growth, is the primary complication following stent implantations across all vascular 
beds. In the coronary vasculature, restenosis requiring revascularization occurs in over 
20% of patients [23, 76]. Rates of restenosis between 10-15% have also been reported in 
the peripheral arteries [4, 106, 110]. In an effort to reduce restenosis, drug-eluting stents 
(DES) have been developed in which bare-metal stents (BMS) are coated with an 
antiproliferative pharmaceutical agent to suppress smooth muscle cell (SMC) growth that 
leads to restenosis. Though DES have decreased the incidence of restenosis compared to 
BMS, retrospective studies of DES still report restenosis rates as high as 10% [48, 67, 74, 
121]. Moreover, by inhibiting SMC growth, DES also inhibit the growth or migration of 
endothelial cells atop stent struts [32, 46]. The lack of a confluent layer of endothelial 
cells over stent struts increases the susceptibility of the artery to late stent thrombosis. In 
the coronary vasculature, the incidence of late stent thrombosis is only 1%, but it results 
in acute myocardial infarction in 40-70% of cases [44, 55]. DES are less commonly used 
in the peripheral arteries, but it should be noted that late stent thrombosis in supra-aortic 
arteries can result in ischemic stroke [20]. 
As noted above, advancements in stent technology have decreased the prevalence 
of adverse clinical outcomes to about 10%, but the affected population is still rather large 
given that over one million stents are implanted each year [28]. Based on a large body of 
evidence suggesting hemodynamic forces influence the vascular response following stent 
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implantation, this thesis aims to develop new techniques to investigate these forces with 
the goal of further improving stent design and clinical outcomes. 
1.2 Patterns of wall shear stress influence the progression of cardiovascular disease 
Wall shear stress (WSS), defined as the tangential force imposed on the vessel 
wall by blood flow, plays an important role in the autoregulation of vessel caliber and 
vascular remodeling. In general, arteries remodel to preserve a homeostatic level of WSS. 
Increases in WSS caused by a decreased lumen diameter or increased flow have been 
shown to cause outward arterial remodeling [36, 47]. Furthermore, extremely high values 
of WSS are associated with vessel remodeling responsible for aneurysm initiation and 
progression [38, 102]. Conversely, regions of low WSS correlate with inward vascular 
remodeling and the progression of atherosclerosis [54]. This relationship between 
vascular remodeling and WSS suggests that stents designed to preserve the homeostatic 
level of WSS may suppress the progression of atherosclerosis and tissue growth that 
leads to restenosis. 
1.3 Stent implantation alters local hemodynamics 
Though stents are designed to reduce alterations in hemodynamics that lead to 
atherosclerosis and aneurysm formation, stent implantation may also induce detrimental 
changes in the local hemodynamic environment. Stents impart a chronic radial force 
resulting in a large compliance mismatch between the vessel and the more rigid stent [15, 
57]. The disparity in compliance at the ends of the stent introduces sites of pressure wave 
reflection that create flow disturbances in the stented vessel [1, 80]. More importantly, 
stent implantation introduces localized areas of low WSS and flow stagnation near stent 
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struts [16, 56]. In an in vivo study of stents implanted in rabbit iliac arteries, it was 
determined that these areas strongly correlate with increased neointimal hyperplasia that 
leads to restenosis [63]. Additionally, areas of complex flow near stent struts facilitate 
platelet deposition onto the arterial wall which likely affects the progression of late stent 
thrombus formation in the absence of a confluent layer of endothelial cells [24, 29]. 
1.4 Design and geometry affect the outcome of stent implantation 
Not all stents alter local hemodynamics in the same manner. Previous animal 
studies indicate that the arterial response to stent implantation varies depending on the 
stent design. For example, Rogers and Edelmen studied the difference between coronary 
stent designs by implanting stents with two different configurations but identical 
diameters, surface area and material into the iliac arteries of rabbits [93]. They found that 
simply changing the stent configuration could reduce vascular injury, thrombus and 
neointimal hyperplasia. Similarly, Sadasivin et al. induced saccular aneurysms in rabbit 
carotid arteries to analyze various flow diverting stents and determined that increased  
pore density generated a greater amount of flow stasis in the aneurysm subsequently 
improving stenting success [94]. In both of these examples, the disparity in stent 
performance can likely be attributed to the difference in the hemodynamic environment 
create by the stent geometry. 
1.5 Quantifying stent-induced changes in hemodynamics 
Hemodynamic indices (i.e. pressure, velocity, WSS etc.) associated with stent 
implantation are difficult to quantify in vivo. Noninvasive imaging techniques such as 
ultrasound and phase-contrast magnetic resonance imaging can measure in vivo blood 
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velocity, but these systems lack the resolution necessary to accurately compute WSS 
following stenting implantation [50]. Even if imaging systems could accurately measure 
WSS, often these systems only quantify WSS in a two-dimensional plane. Computational 
fluid dynamics (CFD) provides a practical means of modeling arterial blood flow to 
overcome the limitations of current imaging technology. Assuming the vessel geometry 
and blood flow can be accurately recreated, CFD models enable hemodynamic indices to 
be quantified in three dimensions, and the use of high density computational meshes 
facilitates the detailed investigation of hemodynamic indices near stent struts.  
Furthermore, CFD can be used to provide estimates of stent performance without 
necessitating the high cost of stent manufacturing or clinical models. 
1.6 Thesis motivation and specific aims 
 While previous CFD studies of stent performance have been invaluable, they have 
often been confined to simplified stent models, idealized vascular representations and 
only compare a handful of possible designs. The objective of this thesis is to address 
these limitations by developing robust computational methods to better evaluate current 
and emerging stent designs based on their hemodynamic performance. The development 
of these tools can be organized into the two specific aims described below. 
SPECIFIC AIM 1: Develop and demonstrate a rapid and computationally inexpensive 
method to virtually implant current and next-generation stents into patient-specific 
computational fluid dynamics models 
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 This investigation builds on a previously described methodology for modeling 
stents in simple patient-specific geometries reconstructed from medical imaging data 
[116]. The method is improved to facilitate the modeling stents in complex patient 
geometries and rapid parametric analysis of commercially available stent designs. 
Additionally, advanced quantification methods are developed to analyze hemodynamic 
stent performance within irregular patient-specific geometries. The applicability of the 
method is demonstrated using patient-specific models of a stented coronary artery 
bifurcation and basilar trunk aneurysm. 
SPECIFIC AIM 2: Construct a computational framework which couples an established 
optimization algorithm with computational fluid dynamics to improve cardiovascular 
stent design. 
 The solid model generation, CFD simulation and WSS quantification used to 
evaluate stent performance is coupled with the surrogate management framework [73] to 
construct a fully-automated computational algorithm for optimizing stent designs. The 
framework is used to determine the optimal configurations of a simple slotted-tube stent 
along with three commercially available coronary stent designs.   
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Chapter 2 
  
A Rapid and Computationally Inexpensive Method to 
Virtually Implant Current and Next-Generation Stents into 
Patient-Specific Computational Fluid Dynamics Models 
2.1 Introduction 
Computational fluid dynamics is often used to quantify hemodynamic alterations 
induced by stenting, but frequently uses simplified computational models of deployed 
stents and idealized vascular geometries [60, 61]. Solid mechanics, or finite element 
analysis (FEA), studies of stent expansion with subsequent flow analysis undoubtedly 
offer an ideal approach for scrutinizing devices, but involve several potential limitations. 
For example, these studies are typically performed with only a portion of the stent, 
representing a few millimeters in length, but the typical length of stents implanted in the 
superficial femoral arteries can exceed 100 mm in length. A finite element approach may 
also require the non-trivial process of converting a discrete finite element mesh into a 
parametric surface to create CFD meshes [11]. Moreover, patient-specific modeling of 
stent implantation using solid mechanics would further increase the time and 
computational cost of an already computationally expensive CFD simulation process. As 
a result, a full-scale analysis of this type is rare. 
The objective of this investigation was to develop a rapid and robust method for 
assessing the influence of current and next-generation stents on patient-specific local 
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hemodynamics and vascular biomechanics quantified by CFD. As opposed to a full-scale 
approach of solid mechanics modeling with subsequent CFD, the post-implantation 
deformation of strut linkages for a portion of the investigated stent is determined using 
finite element analysis or microscopy if the expanded orientation of linkages is not 
previously known, and computer aided design (CAD) is then used to propagate the 
knowledge of strut deformation throughout the full length of a stent for virtual 
implantation into patient-specific CFD models. The sections below begin with a 
description of the methods used to virtually implant commercially available, next 
generation or prototype stents within a CFD model along with techniques for quantifying 
their hemodynamic performance. The use of this new method is then applied in two case 
studies using patient-specific CFD models generated from the coronary and cerebral 
portions of the arterial vasculature. Importantly, each of these examples highlights the use 
of these methods to investigate current clinical sequelae and potential sources of long-
term morbidity thought to be influenced by adverse hemodynamic alterations. 
2.2 Model construction and simulation methods 
2.2.1 Patient-specific CFD model creation 
 Computational representations of the vasculature were created using Simvascular 
open-source software (https://simtk.org/home/simvascular), which facilitates volume 
visualization and conversion of medical imaging data into geometrically representative 
computer models (Figure 2.1: A1-A3). The process involves finding the centerline path 
of each artery, performing segmentation to delineate the arterial wall and connecting 
these segments to form a Parasolid model (Siemens, Plano, TX)[118]. In cases where the 
stent-to-artery deployment ratio used clinically would alter the global geometry within 
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the stented region (i.e. for balloon-expandable stents) physician guidance is required to 
alter segments within the stented region of the vessel according to standard interventional 
procedures [93, 109]. 
 
Figure 2.1: Method of patient-specific model construction. Imaging data, shown as a 
volume rendering (A1), is used to generate vessel centerlines and 2-D segments of the 
arterial geometry (A2). The segments were lofted together to create a 3-D solid model 
(A3). A parameterized sketch of the stent cell (B1) is wrapped around a thick tube (B2) 
and propagated along the length of the tube to create model of a thick stent (B3). The 
thick stent is flexed to match the arterial geometry (B4). The solid vessel (C1) is 
hollowed to radial thickness equal to that of the stent, such that the intersection of the 
thick model of the stent and thin vessel (C2) yields a patient-specific stent (C3) that is 
subtracted from the solid model to produce the flow domain (C4). 
2.2.2 Creation of stent models 
The approach discussed below requires knowledge of the expanded orientation of 
strut linkages. If not known, this information can be determined in a number of ways 
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including performing FEA for a portion of the stent [83, 113] or deploying a stent and 
quantifying the orientation of its strut linkages using light microscopy or microfocal x-ray 
computed tomography [83, 91]. A CAD drawing of the expanded stent pattern is then 
created. The drawing is constrained using a set of equations and other criteria that allow 
the user to easily control specific features of the model (Figure 2.1: B1). This parametric 
approach allows for properties including the number, width and circumferential or 
longitudinal spacing (i.e. scaffolding) of struts, as well as the implantation diameter and 
stent length, to be easily adapted using variables. The drawing, and subsequent stent 
model, can then automatically be regenerated for rapid parametric analysis of the 
contribution of these design properties to resulting hemodynamic alterations. 
The drawing of the expanded stent is wrapped around a tube with a diameter 
slightly larger than the vessel in which the stent will be virtually implanted and a 
thickness >5-times the desired stent thickness. The cell geometry of the stent is then cut 
out of the tube, resulting in a stent design that accurately represents a commercially 
available stent with an accentuated radial thickness (Figure 2.1: B2-B3). Each stent 
design in this study was created using CAD software capable of saving a Parasolid 
document such as Solidworks (Solidworks Corp., Concord, MA) or SolidEdge (Siemens, 
Plano, TX) in order to facilitate integration of the vessel and stent models.  
2.2.3 Virtual stent implantation 
 Virtual stent implantation is achieved using a series of Boolean operations. The 
thick stent is flexed to match the curvature of the vessel (Figure 2.1: B4). A separate solid 
model of the vessel to undergo virtual stenting is created and hollowed to the desired 
stent thickness (Figure 2.1: C1). A Boolean intersection operation is then performed with 
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the hollowed vessel and thick stent to yield a computational representation of the stent to 
undergo virtual implantation (Figure 2.1: C2-C3). Then a Boolean subtraction operation 
is performed with this stent and the patient-specific model in order to remove the stent 
from the lumen and generate the flow domain for CFD analysis (Figure 2.1: C4). In the 
presence of branching arteries, the Boolean intersection that yields the patient-specific 
stent is performed only on the main vessel, with any branching arteries removed from the 
model. The subsequent subtraction of the patient-specific stent is performed on the entire 
model of the vasculature such that the struts of the stent partially occlude the branching 
arteries. 
2.2.4 Specification of CFD boundary conditions and simulation parameters 
Boundary conditions varied slightly between applications and specific details 
unique to each vascular bed will be presented in the subsequent examples. Generally, 
inlet boundary conditions were obtained from experimental data [33, 57] and outlet 
boundary conditions that replicate measured blood flow and pressure were applied. To 
replicate the physiologic influence of vessels distal to CFD model branches, a three-
element Windkessel representation was imposed at model outlets using a coupled-
multidomain method [112]. The three-element Windkessel method provides a good 
estimate of the arterial tree beyond model outlets [105] and can be described by three 
main parameters with physiologic meaning: Rc, C and Rd. Rc is the characteristic 
impedance representing the resistance, compliance and inertance of the proximal artery of 
interest, C is the arterial capacitance and represents the collective compliance of all 
arteries beyond a model outlet, and Rd describes the total distal resistance beyond a given 
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outlet. The procedure for calculating the Windkessel parameters at each outlet is as 
follows: 
1) Compute the total resistance (Rt) for the entire model based on mean blood 
pressure (BP) and flow (Q) measurements. Note that BP=Q*Rt. 
2) Estimate the total arterial compliance (TAC) for the entire model from 
measured inflow and BP measurements using the pulse pressure method 
[105]. Assume a Rc:Rt ratio of 6%, where Rt= Rc+Rd [65]. 
3) Distribute TAC and Rt among the model outlets according to the blood flow 
distribution to the outlets. Tune the Rc:Rt ratio at each outlet using the pulse 
pressure method thereby replicating the desired BP values at each outlet [105]. 
Blood was assumed to behave as a Newtonian fluid with a density of 1.06 g/cm3 
and dynamic viscosity of 4 cP. Three or four cardiac cycles were run to ensure simulation 
results were converged with a maximum error between equivalent time points in 
successive cardiac cycles <1 mmHg and 1 mm3/s for pressure and flow, respectively. The 
simulation time-step was chosen for a Courant, Friedrichs and Lewy condition <1. 
Simulations were also scrutinized to ensure results were independent of the number of 
mesh elements in each model. Anisotropic meshes were created with unstructured 
tetrahedral elements using a commercially available, automatic mesh generation program 
(MeshSim, Simmetrix, Clifton Park, NY). Initial meshes were generated such that the 
density of elements around the stent struts was much greater than throughout the rest of 
the model. Meshes were further adapted after each pulsatile simulation to place more 
elements near struts and other regions where they are most needed within the flow 
domain while inserting fewer elements where a coarse density is sufficient [84]. The 
13 
 
desired mesh independence criteria strived for a change in time-averaged WSS values 
<0.1 dynes/cm2 at predetermined proximal and distal intrastrut regions between 
successive meshes [56, 87]. Simulations were performed using a stabilized finite element 
method to solve equations for conservation of mass (continuity) and balance of fluid 
momentum (Navier-Stokes). Vessel wall elastodynamics equations were also solved in 
cases where a deformable model was used to define the vessel wall[112]. 
2.3 Simulation quantification methods 
 The following portion describes the post-processing techniques for quantifying 
and visualizing hemodynamic indices associated with stent performance. While they are 
presented as a general set of quantification methods, these techniques may not be 
applicable to all stenting scenarios. For example, the turbulent kinetic energy described 
below is often quantified in aneurismal geometries, but it would not be investigated in a 
study of coronary stents where flow is largely laminar. 
2.3.1 TAWSS, OSI and displacement computation and visualization 
After verifying that simulation results were mesh independent and replicated 
aimed BP and flow distributions, time-averaged wall shear stress (TAWSS) and 
oscillatory shear index (OSI) were computed over the last cardiac cycle as previously 
described [108]. Specifically, TAWSS was computed at each node on the surface of the 
CFD mesh as: 
𝑇𝐴𝑊𝑆𝑆 =  �1T�𝑊𝑆𝑆���������⃑  𝑑𝑡T
0
� 
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where 𝑊𝑆𝑆���������⃑  is the WSS vector at a node and T is the period of one cardiac cycle. 
Similarly, OSI was computed at each surface node as: 
𝑂𝑆𝐼 =  12�1 − �1𝑇 ∫ 𝑊𝑆𝑆���������⃑  𝑑𝑡𝑇0 �1
𝑇 ∫ �𝑊𝑆𝑆
���������⃑ �𝑑𝑡
𝑇
0
�𝑊𝑆𝑆���������⃑  
OSI is a measure of the directionality of WSS in which lower OSI values indicate WSS is 
oriented predominately in the primary direction of blood flow while a value of 0.5 is 
indicative of bi-directional WSS with a time-average value of zero throughout the cardiac 
cycle.  
In cases where the model walls were defined as a deformable surface, the 
maximum circumferential strain (𝜖) was computed as: 
𝜖 = 𝑐𝑠𝑦𝑠 − 𝑐𝑑𝑖𝑎
𝑐𝑑𝑖𝑎
  
where csys and cdia represent the vessel circumference during systole and diastole. The 
circumference was measured at a vessel cross-sections perpendicular to the vessel 
centerline. 
2.3.2 Unwrapping the vessel surface geometry 
To better visualize TAWSS, or other relevant hemodynamic indices at the vessel 
wall, the surface geometry of a vessel was unwrapped whereby each (x, y, z) node of the 
surface mesh was mapped to a (θ, l) coordinate system. The dimension θ represents the 
angular position of the node for 0-360 degrees in which the zero degree location was 
arbitrarily chosen, but most often selected to lie along some convenient landmark such as 
the inner or outer curvature of a vessel. The dimension l represents the length along the 
vessel in which the node was located.  
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The length along the vessel was measured relative to the centerline of the vessel. 
Unfortunately, the centerline path created when modeling the vessel geometry from the 
imaging data (Figure 2.1: A1) could not be used to unwrapped the surface geometry 
because it was a user-created path and may not accurately represent the center of the 
vessel. Since θ is measured relative to the centerline, an off-center path would distort the 
θ measurement (Figure 2.2). It was therefore necessary to create an unbiased centerline 
path to unwrap the vessel surface geometry. 
 
Figure 2.2: Comparison of θ quantification with using an off-center and a centered vessel 
path. (Left) A 3D representation of the vessel and the two paths. (Right) Cross-section of 
the vessel with path/plane intersections of the paths denoted. A 90° section of the vessel 
wall is denoted with within the gray shaded areas originating from the two paths. Note 
that the extent of the vessel wall included within the 90° section differs depending on the 
location of the centerline. 
The corrected path was computed using the original, or model construction, path 
as a guide. The model construction path was traversed and planar cross-sections of the 
vessel surface mesh were computed at regular intervals. The center of each cross-section 
was calculated as the center of an algebraic least-squares fit of a circle [34]. The 
computed centers of each cross-section were then used to construct the corrected path. 
Initially, it was proposed the centroid of the cross-section could be used as the center of 
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the cross-section. However, using the centroid caused the correct path to be skewed away 
from bifurcating vessels (Figure 2.3), thus a circle fitting algorithm was adopted. 
 
Figure 2.3: Comparison of algorithms for computing the centerline of a vessel at a 
bifurcation. (Left) 3D representation of the bifurcation and the centerline path computed 
using the centroid (red) and circle-fitting (black) algorithms. (Right) Cross-section of the 
main vessel at the bifurcation. The centroid (red dot) of the vessel is computed using the 
area shaded in gray. Because the branching vessel is removed during the analysis, the 
centroid is skewed away from branch location. The center of the fitted circle (large black 
dot) was computed using the points from the surface of the main vessel geometry (small 
black dots). Note that the fitted circle (black line) provides a good approximation of the 
center of the vessel even when a large portion of the vessel cross-section is removed. 
The corrected path was then used as the reference from which l was computed for 
each node of vessel surface geometry. A Frenet-Serret frame was used to define a local 
coordinate system along the centerline of the vessel. This moving coordinate system 
consisted of a tangent (T), normal (N) and binormal (B=T×N) vector as shown in Figure 
2.4. Using this coordinate system, l was defined for each node as the length along the 
centerline where the surface mesh node intersected the plane defined by the normal and 
binormal vector (NB-plane). The distance (d) between a mesh point (pm) and the NB-
plane was given by: 
𝑑 = 𝑇(𝑙) ∙ 𝑝𝑚 − 𝑇(𝑙) ∙ 𝑝𝑐(𝑙) 
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where pc is the point along the centerline at some length l. The length l along the 
centerline for each mesh point was determined by setting d=0 and solving the remaining 
equation. However, this was not a trivial computation since it is dependent on the 
definition of T(l) and pc(l). The simplest method to define T and pc is using piecewise 
linear interpolation between the points of the corrected centerline, but this results in 
somewhat uneven vessel mapping due to the discontinuities at each point of the 
centerline. For smoother mapping, piecewise Hermite cubic spline interpolation was used 
as it provides C1 continuity at each  point of the centerline [82]. 
 
Figure 2.4: Moving coordinate system used when computing the distance, or length, 
along the centerline path for a point on the surface mesh of the vessel. 
The last step to unwrapping the surface geometry of a vessel was computing the 
angular position, θ, relative to the center for each point on the surface mesh. This 
calculation was performed in the NB-plane. One option for computing angular position 
was to calculate the angle between the vectors (pm – pc) and N, where N is defined as the 
0° position. However, when using a Frenet-Serret frame, N is always directed towards 
the center of the curvature which causes erratic orientation changes, or twisting of the 0° 
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position.  For the purposes of visualizing hemodynamic parameters, it is more desirable 
to use the parallel transport method [17, 37] to minimize the amount of twisting of the 
reference 0° position. Thus, θ was calculated at each point on the surface of vessel 
geometry as the angle between the vectors (pm – pc) and a parallel transport vector 
(Figure 2.5). 
 
Figure 2.5: Comparison of methods for computing the angular position when 
unwrapping a vessel geometry. (Left) The 3D vessel geometry of a stented coronary 
artery. The vessels centerline path is shown along with the vectors indicating the 0° 
position computed using the Frenet-Serret coordinate system (red) and the parallel 
transport method (blue). (Right) Resulting unwrapped vessel computed using the Frenet-
Serret coordinate system (red) and the parallel transport method (blue). The difference 
between the methods is shown using a stented vessel as the stent struts illustrate the 
amount of twisting associated with each method. 
2.3.3 Computing mean exposure time 
Flow stasis was quantified by computing mean exposure time (MET), recently 
defined by Lonyai et al. [71]. Using a particle tracking scheme, MET measures the 
duration massless particles reside within in each element of an MET mesh. In the stented 
models of this investigation, the mesh adaption process created highly anisotropic meshes 
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with more elements along the stent struts, which was not suitable for computing MET. 
Auxiliary isotropic meshes were therefore used as part of a post-processing step for the 
MET calculations since this index depends on element size. To calculate MET for an 
element e, 𝑁𝑒 is defined as the number of times a particle passes through the element, 𝑉𝑒 
as the volume of the element, 𝑁𝑡 as the total number of particles released, and 𝐻𝑒
𝑝(𝑡) as 
equal to 1 when a particle p is located inside the element at time t and is equal to 0 
otherwise such that the MET is given by: 
𝑀𝐸𝑇 = 1
𝑁𝑒𝑉𝑒
1
3�
�� 𝐻𝑒
𝑝(𝑡)𝑑𝑡∞
0
𝑁𝑡
𝑝=1
 
Because the duration a particle resides within an element (i.e. the summation on the right 
side of the MET equation) is normalized by the 𝑁𝑒, MET distinguishes between 
recirculating particles and stagnant particles unlike other flow stasis measurements that 
quantify a cumulative duration. For example, if the duration a particle spends in an 
element is equal to 1.0 second and the particle encountered the element once, the 
computed MET would be higher than a recirculating particle that passes through the 
element twice whose cumulative duration within the element was 1.0 second.  In this 
manner, flow stagnation is weighted higher than recirculation when computing MET. 
In the previous study of MET around venous pacemaker leads, Lonyai et al. also 
normalized the duration a particle resides within an element to 𝑉𝑒 [71]. In this 
investigation the duration a particle resides within an element was instead normalized to 
𝑉𝑒
1
3� , since it was noticed that variations in element size can result in large variations in 
MET if normalized to 𝑉𝑒, as illustrated in Figure 2.6. Given the relatively small element 
size of the auxiliary meshes used in this investigation, it could be assumed particle 
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movement through the elements was highly one-dimensional, and normalizing the 
duration a particle resides within an element to 𝑉𝑒1 3�  reduced variations in MET resulting 
from differences in element volume. 
 
Figure 2.6: A simple example of the variation in mean exposure time (MET) caused by 
differences in element size. A particle moving with a velocity = 1 is shown passing 
through a small cubic element (top) and a cubic element with an edge size twice as large 
(bottom). It is assumed the particle passes through each element once (Ne=1) with a one-
dimensional trajectory, such that the duration (D) the particle resides in the element is 
proportional to the edge size. Using the MET definition of Lonyai et al., MET=D/(NeVe), 
the computed MET differs between the elements due to the large variation in the volume 
of the element (Ve). Applying the MET definition used in this investigation, 
MET=D/(Ne 𝑉𝑒1 3� ), results in a computed MET of 1 for each element. 
 The results of the MET analysis may be sensitive to the strategy with which 
particles are released. There are two primary methods for seeding the computational 
domain, uniformly seeding the entire model or seeding just the inlet. Uniformly seeding 
the entire domain ensures particles populate all regions of the model, but it is likely that 
proximal regions of the model will not encounter as many particles as the distal regions. 
In contrast, seeding the inlet of the model ensures both the proximal and distal regions of 
the vasculature encounter an equal number of particles, but there is the potential that 
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particles would not populate areas of slow or recirculating flow. To overcome the 
disadvantages of both release strategies, a hybrid release strategy was used in which an 
initial uniform seeding of the entire model was supplemented with particles released from 
the inlet of the model over the course of one cardiac cycle. The inlet particles were 
released in a fashion uniform with respect to both space and time such that a greater 
number of particles were released in high velocity areas, shown in the simplified example 
in Figure 2.7. After one cardiac cycle, the inlet release was ceased, and the MET analysis 
was continued for additional cycles until all the particles exited the domain. 
 
Figure 2.7: A simple, two-dimensional example of a particle release into steady flow at 
the inlet of an ideal tube. Particles are shown as being released from the inlet (diameter = 
1) at uniformly spaced locations (spacing = 0.1). The timing of the particle release is 
computed such that additional particles are released at each location in a similarly 
uniform fashion.  
 In addition to the particle release strategy, the density of particles released likely 
influences the results of the MET analysis as well. To analyze the effect of particle 
density, MET analyses with different particle densities were performed for both the 
coronary and cerebral stenting applications. In each case, the first analysis was performed 
with about 1.5 million particles, followed by a second analysis with about 3 million 
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particles and third with about 6-7 million particles. To examine the effect of particle 
density within the entire geometry, a histogram, or discrete probability density function 
(PDF), was computed to characterize the distribution of MET for both the low, medium 
and high particle density MET computations. The PDF bin size was 0.0025 s/cm over a 
range of 0 to 0.4 s/cm. For both the coronary and cerebral applications, a bin to bin 
comparison of the MET histograms revealed a maximum difference >20% between the 
low and medium particle density MET computations but a maximum difference <2.5% 
between the medium and high particle density releases. Thus, MET computations 
performed with 3 million particles were assumed to adequately resolve the MET field, 
but the results of the high density releases are reported in the subsequent examples given 
that these results were already computed for this analysis. 
To facilitate several MET analyses with a large number of particles, the MET 
code was ported to a computer cluster and parallelized to improve the speed of the 
analysis. Unlike the parallel CFD solver, the MET code was not parallelized by splitting 
up the model geometry. Instead, the entire model and CFD results were distributed to 
each processor and the particle release was split among the processors. This 
parallelization strategy was chosen to minimize the amount of data transferred between 
the processors. This is best illustrated with a simple example. Consider an MET analysis 
split up among five processors. Each processor would receive a copy of the CFD results 
but would only be assigned about 1/5 of the particles. After each processor completes its 
analysis, the computed MET for each processor is combined on an element by element 
basis to produce the complete MET analysis. This parallelization strategy is most 
efficient when the number of particles assigned to each processor is equal. Since the 
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speed of the MET code on one processor is proportional to the number of particles 
released, an uneven distribution causes processors with a greater number of particles to 
create a bottleneck for the entire analysis. For this reason, it is not efficient to parallelize 
the particle release based on time (e.g. Five processors, each processor advects the 
particles released during 1/5 of the cardiac cycle), because more particles would be 
assigned to processors that analyze systole than those that analyze diastole. As shown in 
Figure 2.8, distributing the particle release among the processors based on flow rate 
results in an equal and more efficient distribution of particles among the processors. 
 
Figure 2.8: An example of time based and flow rate based strategies for distributing the 
particle release among multiple processors to compute MET. In this example, the release 
of six million particles over one cardiac cycle is distributed among five processors. The 
portion of the particle release assigned to each processor is denoted by the alternating 
gray and white areas under the flow waveform. The number of particle assigned to each 
processor is also denoted (in millions). 
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2.3.4 Computing turbulent kinetic energy 
Turbulence was quantified as the cycle-to-cycle variation within the velocity field 
as previously described [95]. Once simulations were considered converged, four more 
cardiac cycles were simulated, resulting in five well-converged cycles. An ensemble-
averaged velocity for each time point within the cardiac cycle was then computed over 
the last five cycles. Subtracting the ensemble-averaged cycle from the original velocity 
field results in the fluctuating component of the velocity, 𝑢��⃑ (?⃑?, 𝑠). Mathematically, the 
fluctuating velocity field can be used to compute the turbulent kinetic energy as: 
𝑇𝐾𝐸(?⃑?, 𝑠) = 12𝜌[〈𝑢�12〉(?⃑?, 𝑠) + 〈𝑢�22〉(?⃑?, 𝑠) + 〈𝑢�32〉(?⃑?, 𝑠)],∀𝑠 ∈ [0,   𝑇) 
where T is the period of the one cardiac cycle, ρ is the density of blood, 𝑢�1, 𝑢�2, and 
𝑢�3represents the x, y, and z components of the fluctuating velocity, and 〈𝑢�〉(?⃑?, 𝑠) denotes 
an ensemble average of a fluctuating velocity component. Similarly, the ensemble-
averaged kinetic energy (KE) is computed as: 
𝐾𝐸(?⃑?, 𝑠) = 1
2
𝜌[〈𝑢12〉(?⃑?, 𝑠) + 〈𝑢22〉(?⃑?, 𝑠) + 〈𝑢32〉(?⃑?, 𝑠)],∀𝑠 ∈ [0,   𝑇)   
where 𝑢1, 𝑢2, and 𝑢3 represents the x, y, and z components of the ensemble averaged 
velocity.  Finally, the ratio of TKE\KE was computed at peak systole. 
2.4 Case Study 1: Comparing the hemodynamic alterations between stents after 
virtual implantation across a coronary bifurcation 
 In the coronary vasculature, the stenting of bifurcation lesions, which accounts for 
15-20% of treated lesions, is associated with high rates of restenosis and thrombosis [44, 
98]. To date the majority of bifurcation stenting studies has analyzed the effects of 
various single and multiple stenting strategies. Because a large emphasis has been placed 
25 
 
on the stenting technique, very little is known about the potential influence of stent 
design when used to treat bifurcations. Thus, the objective of the case study was to apply 
the virtual stenting method to characterize the hemodynamic differences between two 
stent designs placed across a bifurcation. It should be noted that the predominant 
bifurcation stenting technique is main vessel stenting with provisional side branch 
stenting [103], which results in the presence of stent struts across the ostium of the side 
branch. For this reason, both the local hemodynamics within the main vessel and side 
branch need to be considered when examining the hemodynamic performance of each 
stent. 
2.4.1 Methods 
 A CFD model was created as described above from computed tomography data 
obtained from the OsiriX medical imaging repository (http://pubimage.hcuge.ch:8080/). 
The patient did not have a significant stenosis and the left anterior descending (LAD) and 
first diagonal branch diameters, branch angle and radius of curvature matched published 
normal values [30, 90]. Computational representations of an open-cell ring and link 
design (Stent A) and a close-cell slotted tube prototype design (Stent B) created through 
contract manufacturing for use with experimental investigations were virtually implanted 
using the methods described above (Figure 2.9). The resulting stented vessels mimicked 
the clinical practice of main vessel stenting without subsequent side branch balloon 
angioplasty.  
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Figure 2.9: Coronary model in which an open-cell ring and link, Stent A, and a closed-
cell slotted-tube, Stent B, design were virtually implanted. 
An LAD blood flow waveform at rest [56] was applied at the model inlet. At the 
outlets, the three-element Windkessel was applied, although in the coronary vasculature 
the Windkessel parameters are difficult to compute as ventricular contraction causes 
time-varying changes in resistance [53]. Van Huis et al. demonstrated that the in the 
absence of ventricular contraction the system can be assumed as linear, and the zero hertz 
impedance, Z0, is between 22-65% less than the total resistance [111]; therefore the total 
resistance total resistance (Rt), was scaled by 65% to fall with this range. The 
characteristic impedance (Rc), was calculated from the pulse wave velocity of coronary 
arteries as [111]: 
 𝑅𝑐 = 𝜌∙𝑐𝑝ℎ𝜋𝑟2  
where ρ is the density of blood, cph is the arterial pulse wave velocity, and r is the artery 
radius. A pulse wave velocity of 8.6 m/s was used in this investigation [5]. Given, Rc and 
the scaled Rt, the arterial capacitance parameter was computed as described earlier to 
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replicate the desired BP. At the vessel wall, the stent was modeled as rigid while the 
vessel was modeled as deformable. The modulus of elasticity and thickness of the vessel 
wall were selected to match the deformation previously observed during resting flow 
conditions [89]. 
Previous studies have demonstrated that distributions of TAWSS <4 dyn/cm2 and 
high temporal oscillations in WSS quantified by OSI are associated with cellular 
proliferation, intimal thickening and inflammation [39]. In addition to unwrapping the 
vessel geometry to visualize these hemodynamic parameters, the area of the stented 
region exposed to TAWSS <4 dynes/cm2 and the area of the lumen surface containing 
OSI >0.1 were quantified. Due to differences in intrastrut area (i.e. scaffolding) and the 
number of strut linkages between the similarly sized stents, TAWSS and OSI were 
normalized to the overall area of the stent interfacing with the luminal wall. Vessel wall 
strain was quantified within each intrastrut area at the point of the largest wall 
displacement. MET was computed at the bifurcation to visualize flow stasis in both the 
main and side branches induced by stent placement. 
2.4.2 Results 
Two stented models and a corresponding unstented model of a coronary 
bifurcation were created using the described method of stent implantation. The stent 
creation and implantation into the previously built vessel geometries was accomplished in 
12-16 hours for each coronary stent. CFD simulations of the final stented coronary 
meshes (3.2 million elements) took about 2.9 hours per cardiac cycle, whereas the 
unstented coronary geometry (2.2 million elements) took 1.75 hours per cardiac cycle.  
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 Distributions of TAWSS in the coronary arteries for the two stent types are 
illustrated in Figure 2.10. The main branch stent struts induced non-uniform distributions 
of WSS in the side branch immediately distal to the stent (Figure 2.10, epicardial and 
myocardial inserts). Regions of low TAWSS (<4 dynes/cm2) were localized near the 
struts and more prevalent distal to the bifurcation in both stent models. The total intra-
strut area of the lumen exposed to low TAWSS was higher for the open-cell ring-and-link 
design (Stent A) (75.6%) than the close-cell slotted-tube design (Stent B) (59.3%). The 
curvature of the model caused localized areas of low TAWSS along the myocardial side 
of the LAD lumen in both models. Analysis of the unstented model (results not shown) 
revealed the amount of lumen exposed to low TAWSS due to native vessel geometry is 
5.8%, thus the amounts of stent-induced low TAWSS are 69.8% and 53.5%. There were 
only modest differences in the area of the luminal surface exposed to high OSI between 
the two stent models (<1% for both models), but localized areas of high OSI were found 
to correspond to areas of low TAWSS along the myocardial lumen surface just distal to 
the bifurcation. 
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Figure 2.10: Comparison of hemodynamic indices between coronary Stent A and Stent 
B. Time-averaged wall shear stress (TAWSS) is shown on the vessel (left) and the inserts 
show the distribution at the bifurcation as a result of partial side branch occlusion. The 
main branch of the vessel was unwrapped to visualize intrastrut TAWSS and vessel wall 
displacement. 
 Displacement of the wall in the intrastrut region was ten times less than that in 
other portions of the LAD (Figure 2.10). The larger open-cell geometry of Stent A 
allowed for a greater intrastrut peak displacement. However, the closed-cell design of 
Stent B allowed for a greater average circumferential wall strain due to the pattern of wall 
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deformation within the intrastrut region (0.0035 vs. 0.0040). These values were much less 
than the strain of vessel wall distal to the stent which was near 0.03. 
 Approximately 6.2 million particles were released in each bifurcation model over 
the course of one cardiac cycle and tracked for an additional 19 cardiac cycles to compute 
MET. Figure 2.11 illustrates several cross-sections of the MET field (computed with 6.2 
million particles) near the bifurcation. Stent implantation increased the region of high 
MET near the wall of the vessel in the main branch (Figure 2.11, bifurcation plane and 
cross-section A). The most pronounced difference in MET due to stent implantation was 
in the side branch, just distal to the stent (Figure 2.11, cross-section B).  In this region, 
the MET mimicked the stent design, placement, and number of struts in the side branch 
which caused MET near the center of the vessel to increase relative to the unstented 
model.  Approximately 1.25 mm distal to cross-section B the MET field of the stented 
models reflected that of the unstented model, with only slight differences in area of high 
MET near the vessel wall. The MET was lowest near the carina of the bifurcation which 
corresponds to increased velocity in this region. 
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Figure 2.11: Cross-sections of the mean exposure time (MET) at the coronary 
bifurcation for one unstented and two stented models. MET is visualized in a plane 
parallel to the bifurcation and three planes perpendicular to the vessel (top, left). The two 
planes in the side branch of the bifurcation (B-C) are separated by a centerline distance of 
approximately 1.25 mm. 
2.4.3 Discussion 
 Several properties of coronary stent design influence local hemodynamics within 
the coronary vasculature, such as strut size, width, deployment ratio, etc [60, 93]. In this 
study, the area of low WSS, an indicator for the localization of neointimal hyperplasia 
and subsequent restenosis, was determined to be greater for the open-cell ring-and-link 
design (Stent A). Since strut radial thickness and deployment ratio were kept constant for 
both stent designs, the higher WSS of the closed-cell slotted-tube design (Stent B) is 
likely the result of a longitudinal stent strut angle which is more aligned in the primary 
blood flow direction [62].   
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Using circumferential strain as a measure of the wall motion, Stent B allowed for 
slightly more wall motion than Stent A. Although somewhat counter-intuitive since initial 
visual inspection of calculated wall displacement indicated Stent A had higher peak 
displacement, the longer longitudinal length of the stent cell geometry of the prototype 
stent allows for a greater amount of strain to be generated in intrastrut regions. It should 
be noted the vessel was modeled with a constant compliance throughout the geometry, 
but compliance may vary spatially due to the presence of atherosclerotic lesions. 
MET in the side branch just distal to the coronary stent is highly influenced by 
both the stent design and stent position (Figure 2.11, cross-section B), and it is difficult to 
predict which stent design performs best. Interestingly, the difference in MET due to 
struts crossing the side branch is quite diminished 1.25 mm distal to the stent (Figure 
2.11, cross-section C), and it is unknown if the small volume of high flow stasis within 
this region is hemodynamically significant. While the effects of stent position were not 
considered in this investigation, Williams and Koo et al. modeled a worst case and best 
case stent position across the side branch in an ideal model and observed minimal 
changes in hemodynamics between the models [117]. Still, additional studies are needed 
to better understand the effects of the stent position on disease progression within stented 
bifurcations. The method of stent implantation demonstrated in this investigation is well-
suited for investigating stent positions due to the control the user has during stent 
placement. 
 
33 
 
2.5 Case Study 2: Quantifying the effect of stent strut size on cerebral aneurysm 
hemodynamics 
 Cerebral aneurysm rupture is the second leading cause of stroke in the United 
States [69]. To avoid rupture, blood flow to an aneurysm can be occluded to promote 
flow stagnation and induce thrombosis by means of surgical clipping or endovascular 
devices including coils and stents. In saccular aneurysms, coiling has been shown to be 
an effective treatment for rupture prevention [79]. Wide-necked aneurysms are more 
difficult to treat, and often a stent is used in conjunction with coiling to facilitate 
thrombosis in these cases [97, 114]. Stent porosity, strut size, and cell geometry have all 
been identified as factors that affect cerebral stent performance [12, 52]. Decreased strut 
size of helical stents has been shown to favorably alter flow in idealized aneurysms 
geometries using particle image velocimetry (PIV) [68]. The objective of this example 
was to evaluate how the strut size of stent designs similar to the commercially available 
Neuroform2 stent (Boston Scientific Neurovascular, Fremont, CA) affects hemodynamics 
in a patient-specific model of a wide-necked aneurysm using the computational stenting 
methods described above. 
2.5.1 Methods 
A cerebral model of a patient with a large basilar trunk aneurysm was constructed 
from magnetic resonance imaging data also obtained from the OsiriX medical imaging 
repository. Three stent designs similar to the Neuroform2 were modeled in an expanded 
configuration using the parametric modeling techniques described earlier (Figure 2.12). 
All stents had the same porosity but their strut size was varied for use in three CFD 
simulations. The number of longitudinal and circumferential repetitions was increased as 
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stent strut size decreased in order to maintain a constant porosity in each model as shown 
by the design specifications in Table 2.1. Though these stents are often used in 
conjunction with coils, only a stent model was placed across the neck of the aneurysm in 
order to isolate and characterize stent performance.  
Unlike the coronary stenting case study, both the stent and vasculature were 
assumed to be rigid. Time-varying waveforms were imposed at the model inlets (2 
vertebral and 2 internal carotid arteries) based on previously characterized flow 
waveforms in this area of vasculature [33]. Three-element Windkessel model 
representations were prescribed at the six outlets of the model (2 anterior, 2 middle, and 2 
posterior cerebral arteries) to match the flow distribution in the Circle of Willis [107]. 
Table 2.1: Design parameters for three cerebral stents with a constant porosity. 
Stent Abbreviation 
Longitudinal 
Repetitions 
Circumferential 
Repetitions Strut Width (µm) 
N2-8x8 8 8 93.7 
N2-10x12 10 12 73.4 
N2-12x16 12 16 65.0 
 
Figure 2.12: Basilar truck aneurysm in which three stents similar to the Neuroform2 
were virtually implanted. 
Vascular remodeling is known to occur in areas of elevated WSS. The area of the 
impact zone (TAWSS >20 dynes/cm2) created by velocity impinging on the aneurysm 
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surface was quantified in addition to the area of low TAWSS <4 dynes/cm2 [41, 78]. To 
quantify flow stasis, each model was virtually clipped at both ends of the stented region 
to isolate the aneurysm following simulation and convergence. MET was then computed 
as previously described by releasing particles at the inlet and throughout the isolated 
geometry.  
2.5.2 Results 
 Three cerebral stent models and one unstented model were created using the 
described method of stent implantation. The stent creation and implantation into the 
aneurysm geometries was accomplished in about 12 hours for the N2-8x8 cerebral stent. 
Subsequent modification of the N2-8x8 design to create the N2-10x12 and N2-12x16 
designs only took about 45 minutes per model. Using 64 cores, the final meshes of the 
stented (3.1 million elements) and unstented cerebral models (3.1 million elements) were 
simulated in 2.3 and 1.8 hours per cardiac cycle respectively. 
  Peak systolic velocity, TAWSS and peak systolic TKE for the three cerebral 
aneurysm stent designs are shown in Figure 2.13. Peak systolic velocity in the dome of 
the aneurysm decreased as stent filament (i.e. linkage) size decreased, as well as the size 
of the high velocity jets through the stent. Decreasing filament size also reduced TAWSS 
on the distal wall of the aneurysm, and caused the area of high TAWSS to move from the 
dome of the aneurysm towards the neck. The area of the impact zone (TAWSS >20 
dynes/cm2) was 7.2%, 3.2%, 2.6% and 1.7% of the total aneurysm lumen area for the 
unstented, N2-8x8, N2-10x12 and N2-12x16, respectively. Similarly, the area of low 
TAWSS (<4 dynes/cm2) was 33.9%, 55.4%, 59.3% and 64.9%. Qualitatively, the TKE in 
the aneurysm was minimal throughout the cardiac cycle. Only mildly unsteady flow was 
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present during peak systole. Volume rendered TKE showed no apparent relationship 
between the TKE and stent filament size (Figure 2.13). Similarly, mean TKE values, 
measured in the stented region (Table 2.2) do not indicate a trend consistent with the 
observed decreases in velocity and TAWSS. The unstented geometry had the largest 
TKE, the N2-12x16 had the lowest TKE, but the N2-10x12 and N2-8x8 have similar 
values of TKE. The basilar artery proximal to the aneurysm had a diameter of 3.6 mm 
and computed peak and mean Reynolds numbers (Re) of 472 and 240 over the cardiac 
cycle, respectively. 
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Figure 2.13: Summary of the hemodynamic indices within the stented cerebral aneurysm 
models. (Top) Magnitude of velocity in a slice in through the center of a cerebral 
aneurysm and stent during peak systole. (Middle) Time-averaged wall shear stress 
(TAWSS) on the lumen of the aneurysm visualized on the distal surface of the aneurysm 
where blood entering the aneurysm impinges on the lumen. (Bottom) Volume rendered 
turbulent kinetic energy (TKE) in the aneurysm at peak systole. The models on the left 
illustrate the position of the velocity slice and the perspectives from which TAWSS and 
TKE were visualized with respect to the basilar (BAS), left posterior cerebral artery 
(LPCA) and right posterior cerebral artery (RPCA). 
 
Table 2.2: Mean turbulent kinetic energy (TKE) and mean kinetic energy (KE) within 
the cerebral aneurysm models during peak systole. 
 No Stent N2-8x8 N2-10x12 N2-12x16 
TKE (g cm-1 s-2) x10-4 5.22 1.64  2.00  0.57 
KE (g cm-1 s-2)  4.14 3.89 5.28 4.28 
TKE/KE Ratio x10-5 9.9 3.83 4.83 1.47 
Mean exposure time within the unstented aneurysm model and the model stented 
with the N2-12x16 stent are shown in Figure 2.14.  MET calculations were performed 
with 6.9 million particles released over the course of one cardiac cycle and tracked from 
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an additional 19 cardiac cycles for each model. As shown in Figure 2.14, the greatest 
increase in MET was near the wall of the model and in the middle of the aneurysm.  The 
stent struts also induced a small area of high MET near the stent/lumen interface (Figure 
2.14 Cross-section B of the N2-12x16). The MET field of the N2-8x8 and N2-10x12 
(results not shown) exhibited similar patterns of MET to those in the unstented and N2-
12x16, with magnitudes greater than the unstented and less than the N2-12x16 models. 
Figure 2.15 illustrates the changes in the PDF and cumulative distribution function, 
computed by integrating the cumulative distribution function (CDF) of the MET field 
within the stented and aneurysm region for the various cerebral models. With decreased 
stent filament size, the PDF shifted towards larger higher MET values. The CDF also 
indicates the unstented model has the highest volume of low MET, whereas the stented 
models have decreased volumes of low MET. 
 
Figure 2.14: Cross-sections of the mean exposure time field at three locations within an 
unstented aneurysm and an aneurysm with the N2-12x16 stent across the aneurismal 
neck. 
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Figure 2.15: Probability density function (PDF) and corresponding cumulative 
distribution function (CDF) of the mean exposure time field within the aneurysm volume 
of four basilar trunk aneurysm models in which various stents were placed across the 
neck of the aneurysm. 
2.5.3 Discussion 
 Within the cerebral aneurysm model, the velocity, MET, and WSS results indicate 
that stent implantation increases flow stasis, and decreased stent strut size further 
increases flow stasis within the aneurysm. Though the porosity of each stent was 
identical, velocity within the aneurysm decreased as the stent strut size decreased and 
reduced the area of the impact zone while increasing the area of low TAWSS. None of 
the stent designs completely eliminated the impact zone, so it is likely vascular 
remodeling would degrade the aneurysm wall in this region. Interestingly, the magnitude 
of TAWSS in the impact zone is similar to that in the basilar artery proximal to the 
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aneurysm, but the tissue response to the WSS stimuli is likely different. Recently Meng et 
al. induced basilar aneurysms in rabbits and found that diseased tissue within an 
aneurysm continues expanding and remodeling even after the hemodynamic stimulus that 
initiated aneurysm formation is removed, unlike healthy vascular tissue which ceases to 
remodel once stress levels return to a preferred physiologic level [77].  
The results did not indicate any relationship between TKE and stent design. 
Overall the low Reynolds number and small TKE values in each aneurysm geometry 
indicates that blood flow in the aneurysm is quite steady, so it is difficult to draw any 
conclusion about chaotic blood flow in this region. If blood flow to this region were 
increased by simulating exercising conditions, differences among the stent designs may 
be more apparent.  
The current findings coincide with those of Lieber et al., who showed that 
decreased filament size correlated with improved hemodynamic results in a previous PIV 
study of helical stents [68]. However, this previous study also observed pronounced stent 
movement with very small filament size which caused increased circulation within the 
aneurysm for the smallest filament size considered. By modeling the stent as rigid, stent 
motion was not considered in the current investigation. Another previous PIV study of 
twenty different stent models, including helical stents, ring-and-link stents, etc., was 
unable to identify a simple relationship between either stent porosity and stent 
performance or stent strut size and stent performance [12]. Since the present work was 
able to quantify the effects of strut size at a constant porosity, future work may include 
repeating this study with the same basic designs, but using parametric modeling 
techniques to model three stents with identical strut size, allowing the porosity of the 
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stents to vary. In this manner, it might be possible to identify which stent design 
parameters have the greatest influence on stent performance in cerebral aneurysms. 
2.6 Discussion of patient-specific modeling techniques 
2.6.1 Summary 
The described virtual stenting method provides a rapid and robust means for 
evaluating the performance of commercially available and next-generation stents in 
patient-specific geometries using CFD. The complexity of the coronary bifurcation and 
large basilar trunk aneurysm models demonstrates the applicability of these methods 
across vascular beds. Though the CFD results were quantified using some custom 
computer programs, the model creation and stent implantation process was completed 
using only open source software and commercially available CAD packages already 
frequently used by stent design engineers. The method provides a process and examples 
of results that were previously difficult or laborious to obtain. Localized changes in 
indices known to correlate with restenosis including WSS can now be obtained for almost 
any conceivable stent design. Results not often reported such as intrastrut displacement 
due to differences in stent-induced scaffolding or parameterized contributions of design 
features to flow stasis can also be obtained rapidly.  
Both vascular geometry and stent design are known to influence the post-
procedural outcomes of stenting in most diseases treated by stenting. The method of 
virtual stent implantation employed in this investigation demonstrates a means of 
representing a complex vessel and full stent geometry to further understand the 
hemodynamic interactions between them. It is worth noting that other ways of virtually 
implanting stents into patient specific vessels have been developed previously [3, 51], but 
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the series of Boolean operations described here are computationally inexpensive to 
include and ensure the stent model is in good apposition to the vessel wall. 
Using the methods outlined in this investigation, most commercially available and 
next-generation stents could be modeled with the exception of braided stents with a 
circular strut profile or other more complicated strut profiles. Stents with complex strut 
profiles could be generated using the same modeling techniques described in this 
investigation when simulating blood flow through ideal vessels, but implanting these 
stents in a patient-specific geometry in which the dimensions of the vessel are not well 
defined is not possible using the current methods. Nevertheless, the current virtual 
stenting process provides a framework for rapidly producing and analyzing various stent 
designs. In this investigation, the deployed configuration of the each stent design was 
modeled as using parametric design techniques enabling rapid generation of several 
variations for a particular stent design. Modeling the stent in a deployed configuration 
further decreased the amount of time necessary to numerically compute the expanded 
configuration of the stent. Three cerebral aneurysm stent models were all generated from 
the same basic design that was created and virtually implanted in the aneurysm model 
within a few hours after establishing the variables for use with the initial stent geometry. 
Given that generating, modifying, and virtual implanting a stent design using the current 
method can be performed quickly, this process of stent modeling is well-suited for design 
optimization. 
In addition to presenting a novel technique of stent implantation, this investigation 
demonstrates post-processing techniques of CFD data which enable a better 
understanding of flow dynamics within stented geometries. Computation of MET 
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provides insight into changes in bulk flow characteristics within a volume of interest 
(Figure 2.14) and pinpoints specific locations of flow stasis (Figure 2.11, Figure 2.13), 
whereas the commonly used metric of aneurysm turnover rate only provide information 
about bulk flow. Moreover, aneurysm turnover is computed by quantifying the flow 
across a plane at the aneurysm inlet. This plane may be difficult to define within irregular 
patient-specific geometries, as was the case in this investigation. This investigation also 
demonstrates an unwrapping technique that facilitates the visualization and comparison 
of CFD results, such as TAWSS and displacement, within stented regions in a manner 
similar to that described by Antiga et al. [2] 
2.6.2 Limitations 
The current results should be interpreted within the constraints of several potential 
limitations. Notably, the stent implantation method does not model the mechanical 
interaction between the stent and the vessel during stent deployment. Accurately 
modeling stent deployment would require more extensive computations and knowledge 
of stent geometry and material along with the vessel geometry and morphology, which 
can be difficult to obtain in vivo. The described methodology does not account for 
compliance mismatch between the stent and vessel wall which often causes vessel 
straightening in curved vessels [42, 83, 115], asymmetric stent deformation across 
aneurysm necks or branching arteries [25, 43], kinking of the stent in regions of acute 
curvatures [25], vessel prolapse into the flow domain [14, 61, 85], or stent malapposition 
[14]. From previous CFD studies of the coronary arteries with and without straightening 
induced by stenting, it would be expected that extreme changes in curvature near the 
proximal and distal ends of stent may induce harmful distributions of WSS that leads to 
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restenosis [59]. Vessel prolapse has been incorporated into idealized CFD models of 
commercial stents and was found to decrease the amount of the vessel exposed to low 
WSS [85]. Conversely, previous idealized models [61] and a more recent study of stent 
deployment in a canine artery ex vivo [14] have found that prolapse of the vessel into the 
flow domain increased levels of WSS; therefore hemodynamic alterations due to vessel 
prolapse likely depends on the stent design and how prolapse is modeled. The ex vivo 
canine model of Benndorf et al. was also used to study stent malapposition in straight 
vessels and identified increased low WSS distal to the malapposition [14]. Although stent 
implantation method described in this investigation does not account for the stent/vessel 
interactions discussed above, visual comparison of the coronary model in this 
investigation to that of Benndorf et al. indicates that deviations from reality appear to be 
modest when this method is used in a relatively straight geometry. In vessels of acute 
curvature, the inability to predict changes in wall curvature and stent kinking are inherent 
limitations of the method described here. Future research on the virtual stent implantation 
methodology will work to address these limitations. 
Modeling large portions of the vasculature in addition to a stent made it difficult 
to achieve mesh independence as defined by a change in time-averaged WSS at 
predetermined proximal and distal intrastrut <0.09 dynes/cm2 between successive 
meshes. In the coronary stenting simulation, this level of accuracy was achieved with ~3 
million elements, but was not attainable in the cerebral aneurysm models due to the 
computational limitations of generating large meshes for vessels over such a wide range 
of sizes. Therefore, conclusions regarding intrastrut distributions of TAWSS were not 
made for these models. Measured levels of TAWSS within a 1.5 mm thick slice of the 
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model proximal and distal to the stent changed by <1% for the cerebral aneurysm model. 
Though mesh-independence was not attained as defined, stent struts extending across the 
neck of the cerebral aneurysm had >5 elements across their face for simulations with the 
densest meshes. 
2.6.3 Virtual stent implantation in retrospective models 
Most of the limitations of the virtual stenting method in this investigation are only 
valid when creating a priori models using the stenting procedure. The method can also be 
used to reconstruct patient-specific geometries post-stent implantation with much greater 
accuracy since the final geometry of the deployed stent and associated vessel is known. 
For example, Figure 2.16 illustrates a modified version of the virtual stent implantation 
method using models constructed from high resolution optical coherence tomography 
imaging data obtain immediately following a stenting procedure [27]. In this case, the 
vessel lumen and outer surface of the stent were segmented and lofted separately to create 
two distinct models (Figure 2.16, A and D). The stent radial thickness was then 
subtracted from the solid model representing the outer surface of the stent (Figure 2.16, 
A). Subtracting the thinner lofted stent model from the thick stent yielded a patient-
specific stent model that mimicked the inner surface of the stent (Figure 2.16, B and C). 
The final subtraction of the patient-specific stent model (Figure 2.16, C) from the lumen 
model (Figure 2.16, E) generated the flow domain used for subsequent CFD simulations 
(Figure 2.16, F).  Using this modeling technique, the stent position is represented as it 
appears in vivo with the only limitation being the inability to model small non-uniform 
expansion of stent cells. Features such as vessel prolapse and thrombosis can also be 
represented in the CFD model.  
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Figure 2.16: Modified virtual stent implantation method that can be used in conjunction 
with high resolution optical coherence tomography imaging data post-stenting procedure.  
2.7 Conclusion 
 In summary, the current investigation describes an efficient method for virtual 
stent implantation in patient-specific models in order to analyze alterations in 
hemodynamics using CFD. Unlike idealized computational models of stent designs, this 
method can be used to quantify differences in stent performance in complex vascular 
models for most stenting procedures, as demonstrated in this investigation through the 
construction of two arterial models with varying degrees of complexity. For each model 
in this investigation, the method of virtual stent implantation was used to quantify the 
potential impact of partially occluding downstream vascular regions by stent struts and 
therefore may be used in future studies to investigate various stenting strategies at 
bifurcations or in response to treatments in order to provide additional insight into ways 
of improving stents for particular portions of the vasculature.  
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Chapter 3 
  
Optimization of Cardiovascular Stent Design Using 
Computational Fluid Dynamics 
 
3.1 Introduction 
While previous CFD studies have provided useful insight for improving stent 
design, they only analyze a small number of possible stent geometries in order to identify 
the general trends that govern stent design. For example, computational studies of 
idealized stent geometries have shown that thinner struts and those more aligned with the 
primary flow direction decrease the amount of low WSS at the arterial wall using only 
three or four models [60, 62].  Similarly, within this thesis (Chapter 2, Case Study 2) only 
three variations of a simple flow diverting stent were modeled to investigate improved 
stent designs. 
 Conversely, incorporating a shape optimization algorithm with a proven 
convergence theory into the design process allows engineers to systematically identify 
the most favorable designs. Previous CFD optimizations of coronary stent design have 
been limited to 2-D stent models or optimizations of a single stent cell [6, 18, 101]. The 
objective of this investigation was to develop a fully automated framework for designing 
hemodynamically optimal coronary stents using CFD of complete, 3D stent geometries. 
While traditional gradient-based optimization methods often require invasive changes to 
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the solver code, therefore limiting potential applications, the use of a derivative-free 
method in this work allowed for a flexible and efficient framework. The utility of this 
framework is then demonstrated with two case studies of coronary stent geometries. The 
first case study examines the relationship between the optimal number of 
circumferentially repeating stent cells (NC) and the intrastrut angle of generic slotted-tube 
stent design. Building on the results of the first case study, the second case study analyzes 
the relationship between vessel diameter and the optimal NC for a generic slotted-tube 
and three commercially available stent designs. For each case study, the stent design that 
best maintains the homeostatic of level WSS was defined as optimal. 
3.2 Methods 
3.2.1 Stent and vessel model construction 
Similar to the technique used for generating patient-specific stent models, stents 
were parameterized and modeled in an expanded state using SolidWorks. However, the 
previous technique for creating stent models (Figure 2.1, B1-B2) required user interaction 
to manually alter stent design parameters. In order for the optimization framework to be 
fully automated, a custom software program was written using the SolidWorks 
application programming interface to generate solid models of stent designs for a given 
set of parameters (Figure 3.1, A). The program did not generate stent models from 
scratch because the steps for modeling commercial stents differ slightly depending on the 
design, which would require a new program to be written for each design. Instead the 
program opened a previously parameterized stent model, altered the specified dimensions 
and rebuilt the model such that the same program could be used for all of the stent 
geometries regardless of the techniques used to create the model. 
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Idealized vessel models were also constructed using SolidWorks. All vessels were 
modeled with a stent-to-artery diameter ratio of 1.1:1 [35], but the length of the expanded 
stented region of the vessel differed depending on the stent design. A 2.0 mm tapered 
section connected the expanded stented section of the vessel to proximal and distal 5.0 
mm sections of unstented vessel [86]. A Boolean subtraction operation was performed to 
remove the stent model from the vessel model resulting in a solid model of the flow 
domain (Figure 3.1, B). 
 
Figure 3.1: Description of the steps necessary for evaluating a stent design. The TAWSS 
is shown normalized to the average TAWSS in the proximal, unstented region of the 
model. 
3.2.2 Computational fluid dynamic simulations 
Solid models of the flow domain were discretized into unstructured tetrahedral 
finite element meshes using MeshSim. The mesh generation was tailored to create one 
highly anisotropic mesh for each model. A coarse mesh was prescribed in the proximal 
50 
 
and distal unstented regions of the vessel, with a finer mesh density prescribed to the 
stented region, and a very fine mesh density pres 
cribed in the intrastrut regions that are later quantified as part of the optimization 
routine (Figure 3.1, C). Using highly anisotropic meshes ensured the near-wall 
hemodynamics were well resolved within the portion of the model later quantified by the 
optimization routine without incurring the high computational cost of dense isotropic 
meshes. 
The boundary conditions prescribed to the discretized stent model were similar to 
those used for the patient-specific coronary bifurcation model (Section 2.4.1). Briefly, the 
artery was assumed to be rigid and a no-slip boundary condition was prescribed on the 
vessel and stent surfaces. Blood was assumed to be a Newtonian fluid with a density of 
1.06 g/cm3 and a viscosity of 4 cP. A time-varying canine left-anterior descending 
coronary artery flow waveform [57] with characteristics similar to those found in humans 
was imposed at the model inlet using a Womersly velocity profile (Figure 3.1, D). The 
inflow rate was not scaled for different diameter vessels. Outlet boundary conditions 
were prescribed using a three-element Windkessel approximation to replicate the 
physiologic impedance of the downstream vasculature (Figure 3.1, D). The outlet 
boundary conditions were modified to account for the resistance of ventricular 
contraction as previously described (Section 2.4.1). 
 CFD simulations were run using an in-house stabilized finite element solver with 
commercial linear solver component LESLIB (Altair Engineering, Troy, MI) to solve the 
time-dependent Navier-Stokes equations. The time-step was chosen for a Courant, 
Friedrichs and Lewy condition <1. Simulations were run until the outlet pressure and 
51 
 
flow were periodic, defined as a maximum error between equivalent points in successive 
cardiac cycles <1 mmHg and <1mm3/s. TAWSS was then computed over the last cardiac 
cycle as previously described (Section 2.3.1). Cells in the middle of the stented region 
were extracted for subsequent evaluation in the optimization routine (Figure 3.1, F).  
3.2.3 Computing design cost 
The formulation of the optimization cost function was based on the physiologic 
theory of TAWSS homeostasis, which suggests vessels remodel to maintain a nominal 
level of TAWSS. Favorable stent models were defined as those which would 
theoretically attenuate vascular remodeling within the stented region by minimizing the 
disparity between TAWSS in the stented region of the model (𝑇𝐴𝑊𝑆𝑆����������𝐼𝑆) and the 
nominal level of TAWSS in the unstented region of the model (𝑇𝐴𝑊𝑆𝑆����������𝑈𝑆). Thus the 
design cost (J) of a stent model was expressed using a ratio of 𝑇𝐴𝑊𝑆𝑆����������𝐼𝑆 to 𝑇𝐴𝑊𝑆𝑆����������𝑈𝑆 as: 
 𝐽 = 1 − 𝑇𝐴𝑊𝑆𝑆����������𝐼𝑆
𝑇𝐴𝑊𝑆𝑆����������𝑈𝑆
  
in which 𝑇𝐴𝑊𝑆𝑆����������𝐼𝑆 is defined as the integration of TAWSS over the intrastrut surfaces (s) 
normalized to the area of those surfaces: 
 𝑇𝐴𝑊𝑆𝑆����������𝐼𝑆 = ∫ 𝑇𝐴𝑊𝑆𝑆 𝑑𝑠𝑠
∫ 𝑑𝑠𝑠
  
The value of 𝑇𝐴𝑊𝑆𝑆����������𝐼𝑆 was computed over the intrastrut regions with the highest mesh 
resolution (Figure 3.1, C). This computation also mitigated any effects of slightly varying 
stent lengths and flow disruptions near the ends of the stented regions. A custom software 
program that used the Visualization Toolkit (VTK, Kitware, Clifton Park, NY) libraries 
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was written to compute the integral described above. The nominal level of TAWSS in the 
unstented portion of the vessel was computed as: 
 𝑇𝐴𝑊𝑆𝑆����������𝑈𝑆 = 4𝜇𝑄𝜋𝑟3   
where Q is the mean flow, µ is the viscosity and r is the vessel radius.  
3.2.4 Optimization routine 
The surrogate management framework (SMF) previously described by Booker et 
al. and applied to cardiovascular engineering problems by Marsden et al. was used to 
determine optimal stent designs [19, 73]. The general formulation of the optimization is 
given by: 
 minimize 𝐽(𝒙) 
 subject to 𝒙 ∈ Ω 
where J represents the cost function for a given vector of parameters x in the domain Ω. 
The SMF framework is a derivative-free optimization algorithm that relies on pattern 
search theory for convergence of the cost function to a local minimum. The method 
restricts all parameters to lie on a discrete parameter mesh that may be refined to increase 
the resolution of the parameter space as the algorithm progresses. The implementation of 
the SMF algorithm in this investigation used a mesh adaptive direct search (MADS) 
polling method, which has  a stronger  convergence theory compared to previous 
generalized pattern search methods [7]. Used by itself, the MADS pattern search method 
may require numerous cost function evaluations to converge on a local minimum, which 
would be detrimental to this investigation since computing the cost of a single stent 
design is computationally expensive (requires model generation, meshing and time-
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dependent CFD). The SMF uses a surrogate function to approximate the “true cost 
function” and predict the location of the local minimum, thereby increasing the efficiency 
of the optimization by reducing the number of cost function computations necessary to 
search for the location of the minimum [19]. Though various surrogate functions can be 
used with the SMF method, this investigation incorporated a Kriging surrogate function  
using the MATLAB DACE package [72] to easily extend this approach to multiple 
dimensions and avoid problems of overshoot found in polynomial interpolation.  
The SMF optimization algorithm is schematically illustrated in Figure 3.2. The 
algorithm is initialized using Latin Hypercube Sampling (LHS) to generate a well-
distributed set of input variables, or trial points, over the discrete parameters space [75]. 
Stent models are constructed and evaluated for each trial point and the resulting cost 
function values are used to construct the initial surrogate function. 
The optimization loop consists of two fundamental steps, SEARCH and POLL. 
During the SEARCH step, the surrogate function is used to predict the location of 
parameters that minimize the cost function. If evaluation of the trial points generated by 
the SEARCH steps improves the current best point, another SEARCH steps ensues. After 
every SEARCH step, the surrogate function is updated to incorporate all new cost 
function values. If the SEARCH step fails to improve the current best point, a POLL step 
is performed. MADS is used to identify a set of n+1 positively spanning POLL points 
that neighbor the current minimizing point, where n is the number of parameters [7]. If 
the POLL step succeeds in improving the current best point, the algorithm returns to the 
SEARCH step. If the POLL step is not successful, then a mesh local optimizer has been 
found, and the optimization algorithm will either complete, or the parameter mesh will be 
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refined. In this investigation, refining the parameter space decreased the parameter mesh 
size (Δm) by ¼. When the POLL step fails and the parameter mesh has been refined to the 
specified tolerance, the optimization algorithm stops. 
 
Figure 3.2: Flowchart of the Surrogate Management Framework optimization routine. 
Each bolded box indicates a point in the routine where the cost function for a stent design 
is evaluated.  The optimization stops when the size of the discrete parameter mesh (Δm) is 
refined beyond a user specified tolerance (tol). 
To fully-automate the optimization routine, the optimization algorithm was 
coupled to the cost function evaluation using TCL scripting capabilities within 
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Simvascular (www.simtk.org). The scripts called external programs to execute the 
optimization algorithm (MATLAB), build models (SolidWorks), perform CFD, and 
compute cost values (VTK). Because MeshSim is directly integrated into Simvascular, 
meshing and prescribing boundary conditions was performed using built-in Simvascular 
subroutines. The majority of the optimization routine was executed on a standard 
personal computer except for the CFD simulations, which were performed on a high 
performance computing cluster. 
During some steps of the optimization routine the parameters of multiple trial 
points may be known, such as during the LHS and POLL steps, in which case the cost of 
multiple stent models can be computed simultaneously for increased efficiency. The 
initial implementation of the optimization framework serially evaluated the cost of 
multiple trial points whereby each stent model was built (model construction and 
meshing), run (CFD) and quantified (compute cost) before another model could be 
evaluated. It was later determined that TCL’s multithreading abilities could be used to 
evaluate trial points in parallel by spawning a new thread to build, run, and quantify each 
model. Using this approach, evaluating multiple models would theoretically take the 
same amount of time as evaluating a single model. Unfortunately, in this investigation it 
was not possible to build several models in parallel due to the memory constraints of the 
desktop computer used. Nevertheless, the CFD simulations could still be run in parallel, 
since this portion of the optimization was performed on a computer cluster in which there 
were no memory constraints. Thus trial points were evaluated in a pseudo parallel fashion 
in which each model was serially built, but a new thread was spawned to run and quantify 
the model. This approach still provided better performance than serially evaluating 
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multiple trial points, but the efficiency of the optimization could be further improved by 
evaluating multiple trial points in parallel in future studies, possibly by transferring the 
modeling building code to high performance computing cluster. The difference between 
serial, pseudo-parallel and parallel is illustrated in Figure 3.3. 
 
Figure 3.3: Comparison of serial, pseudo-parallel and parallel algorithms of evaluating 
multiple trial point during the optimization a stent design. Each algorithm is illustrated 
with a flow chart of the various steps necessary to evaluate the total number (TN) of stent 
models. Note that the parallel and pseudo-parallel algorithms spawn new threads to 
simultaneously execute certain portions of the algorithm and increase the performance of 
the optimization.  
3.3 Case Study 1: Optimization of a generic slotted-tube stent with a constrained 
intrastrut area 
A previous CFD study of slotted-tube stent designs indicated stents which 
minimize the number of stent strut intersections reduce the area of the vessel exposed to 
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potentially deleterious levels of low TAWSS [60]. Because this study only compared two 
stent designs and varied both NC along the number of axial repeating stent cells (NA), it is 
difficult to isolate the hemodynamic effects of either NC or NA. To further understand the 
effects of these parameters, this case study aimed to simply optimize NC. During the 
course of this investigation, it was hypothesized that the strut angle relative to the 
primary direction of flow may dictate the optimal value of NC. Therefore, a second set of 
optimizations was performed to determine if the optimal strut angle correlates with the 
optimal values of NC computed in the first optimization.  
3.3.1 Parameterization of stent models 
Generic slotted-tube stents, similar to the Palmaz-Schatz design, were generated 
from a parameterized stent model in which the cell axial length (la), circumferential 
distance between adjacent struts (lc) and intrastrut angle (θ) could be altered (Figure 3.4). 
Stent strut radial thickness and intrastrut area were explicitly defined to prevent the 
optimization routine from pursuing infeasible stent designs since the objective of 
maintaining the homeostatic level of TAWSS within a stented vessel is ideally met by a 
stent design with negligible strut thickness and large intrastrut areas if these parameters 
are not kept constant. This intuition was confirmed by preliminary optimizations before 
the strut width and thickness were defined as 100µm, similar to the size of an average 
stent. The intrastrut area of commercial closed-cell stents varies between 1mm2 and 
3mm2, and an ideal area is not known. Therefore optimizations were performed with 
intrastrut areas of 1mm2, 2mm2 and 3mm2 (Figure 3.4) to examine the effect of this 
parameter on optimal stent design within the range of commercial stent designs. 
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Figure 3.4: (Top) Parameterized drawing of a stent cell which is characterized by the cell 
axial length (la), circumferential distance between struts (lc) and intrastrut angle (θ). 
(Bottom) Examples of three stent models with different intrastrut areas shown to the left 
of each model. 
Vessels were modeled with an expanded, or stented, length of 18 mm. With the 
addition of an unstented and a tapered section, the total model length was 32 mm. To 
analyze the effect of vessel diameter on optimal stent designs, all optimizations were 
performed in both small (SV) and large vessels (LV) with diameters of 2.25 mm and 3.0 
mm corresponding to stent diameters of 2.475 mm and 3.3 mm, respectively. 
3.3.2 Method for optimizing the number of circumferentially repeating stent cells 
When determining the optimal value of NC for a given stent design the intrastrut 
area and vessel diameter remained constant while NC was allowed to vary. To determine 
the cell geometry for a given NC, lc was computed based on the stent diameter and the 
value of NC specified by the optimization routine. The axial cell length was then 
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computed to maintain a constant intrastrut area of either 1mm2, 2mm2 or 3mm2. Lastly, 
NA was computed to achieve a target stent length of 18mm or less. 
The optimal value of NC was computed for each combination of vessel size and 
intrastrut area for a total of six stent design optimizations. For each optimization, the 
initial parameter mesh was defined to include all possible integer values. The parameter 
mesh was not refined during the optimization since NC was not a continuous variable. 
3.3.3 Method for optimizing the intrastrut angle 
The model construction method described in the previous section could not be 
used to optimize θ because the constraints of an integer number of circumferentially 
repeating cells and a constant intrastrut area only allows for the creation of stent models 
with discrete θ values. Instead, stent models were created in which θ was a continuous 
variable and consequently, NC was also allowed to be a continuous variable. Models 
created using this approach had a repeating strut configuration that propagated around the 
circumference of the vessel, but did not necessarily meet to form a continuous pattern 
(Figure 3.5). While this approach may not create feasible stent designs, it does provide a 
means of investigating the optimal intrastrut angle with fine detail. To create a stent 
model for a given θ, la was first computed to maintain a constant intrastrut area of either 
1mm2, 2mm2 or 3mm2 and subsequently NA was computed to achieve a target stent length 
of 18 mm. 
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Figure 3.5: An example of a stent model that was generated when optimizing the 
intrastrut angle. Note that the number of circumferentially repeating cells was not 
constrained to being an integer resulting in an infeasible stent model that appears broken. 
As with the optimization of the number of repeating circumferential units, the 
optimal θ was computed for each combination of vessel size and intrastrut area. The 
intrastrut angle was a continuous variable so initial parameter meshes were defined as 
have a spacing of 8° with three refinements performed during the optimization. This 
resulted in a final parameter mesh resolution of 0.5°. 
3.3.4 Results of optimization of the number of circumferentially repeating stent cells 
The number of circumferential repeating cells was optimized for stent designs 
with intrastrut areas of 1mm2, 2mm2 and 3mm2 in both large and small vessel models. 
The optimal design parameters are summarized in Table 3.1. For stent designs with 
equivalent intrastrut areas, the optimal number of circumferential repeating cells 
increased with increased vessel size, and the optimal cost was lower in the small diameter 
vessel (e.g. SV-1mm2: NC=7, J=0.590 vs. LV-1mm2: NC=9, J=0.613). Within vessels of 
the same diameter, the optimal cost decreased with increased intrastrut area (e.g. SV-
1mm2: J=0.590 vs. SV-2mm2: J=0.500). Each optimization converged on an optimal 
design using seven or fewer function evaluations. 
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Table 3.1: Results from optimizing the number of circumferentially repeating stent cells. 
Stent Design Cost (J) 
Circumferential 
Repetitions (NC) 
Number of Function 
Evaluations 
SV (Ø = 2.25 mm)    
1mm2  0.590 7 6 
2mm2  0.500 5 6 
3mm2  0.460 4 4 
LV (Ø = 3.0 mm)    
1mm2  0.613 9 7 
2mm2  0.520 7 5 
3mm2  0.477 6 5 
SV=small vessel; LV=large vessel 
Plots of the cost function versus the number of circumferentially repeating cells 
and corresponding intrastrut angles are shown in Figure 3.6. Visual inspection of 
intrastrut TAWSS distributions (Figure 3.6) indicates that designs with less than the 
optimal number of repeating circumferential units exhibited a greater area of low 
TAWSS as a result of struts that were more misaligned with the primary direction of flow 
and decreased cell axial length. Stent designs with greater than the optimal number of 
circumferentially repeating cells also exhibited a greater area of low TAWSS. In this case 
the increased area of low TAWSS resulted from the close proximity of adjacent struts 
which decreased near wall blood flow velocity, and subsequently TAWSS, within the 
intrastrut region. 
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Figure 3.6: The cost function versus the number of repeating circumferential units for 
stent models with various intrastrut areas in a small vessel (left) and large vessel (right). 
The intrastrut angle corresponding to the number of repeating units is denoted on the 
individual plot axes for each design and the optimal design is circled on each plot. 
Patterns of normalized TAWSSIS are shown for the least, most and optimal number of 
circumferential repeating units. 
3.3.5 Results of optimization of intrastrut angle 
When the intrastrut angle was allowed to vary continuously, the optimal θ was 
found to be between 38.5° and 46.5° for all stent designs. This indicates that the optimal 
intrastrut angle is largely independent of the vessel size and intrastrut area. Plots of the 
design cost relative to the intrastrut angle are shown in Figure 3.7 (black lines). For 
comparison, the cost from the optimization of the number of circumferentially repeating 
cells is also shown in Figure 3.7 (gray lines). The optimal number of circumferentially 
repeating cells (Figure 3.7. gray circles) corresponds to the stent design closest to the 
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optimal intrastrut angle, indicating that the intrastrut angle dictates the optimal number of 
circumferentially repeating units. 
 
Figure 3.7: The cost function versus the intrastrut angle for stent models with various 
intrastrut areas in a small vessel and large vessel (black). The intrastrut angles that 
correspond to feasible stent designs are shown as vertical lines (gray). The cost function 
versus the number of circumferentially repeating stent cells is plotted along gray lines 
and the number of circumferentially repeating cells is denoted above the lines for models 
that have been evaluated. Optimal stent designs are circled on all plots. 
The convergence history for the optimization of intrastrut angle is shown in 
Figure 3.8. LHS accounted for the first three function evaluations. Although the 
optimization method allowed for three mesh refinements, all optimization runs converged 
with less than 20 function evaluations, with the majority of runs only requiring 10 to 15 
function evaluations. 
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Figure 3.8: Convergence history for the optimization of intrastrut angle for stent models 
with various intrastrut areas in a small vessel and large vessel. The Latin Hypercube 
Sampling (LHS) portion of the optimization routine is shaded in gray. The Surrogate 
Management Framework (SMF) represents the portion of the optimization algorithm that 
used alternating SEARCH and POLL steps to converge on the optimal stent design. 
3.3.6 Discussion 
The application of the optimization produced two novel findings pertaining to the 
optimal design of a generic slotted-tube stent. The optimal number of circumferential 
repeating stent cells is dependent on the intrastrut angle, and the optimal intrastrut angle 
is independent of both vessel size and the intrastrut area of the stent cell. It should also be 
noted that the inflow waveform to the models was kept constant for both vessel diameters 
in this investigation, which created a large difference in the magnitude of TAWSS 
between the different diameter vessels as a result of the cubic relationship between 
TAWSS and vessel diameter. Thus, it can also be concluded that the optimal intrastrut 
angle is independent of the magnitude of TAWSS. 
The current results confirm and extend the findings of previous stent CFD studies. 
In a previous study of stent foreshortening, stents with intrastrut angles of 58°, 68° and 
78° degrees were constructed, and it was determined that stents with struts more aligned 
with the primary direction of flow decrease the area of low WSS [62]. Because angles 
less than 58° were not tested, this study was unable to determine that further decreasing 
the intrastrut angle (<40°) would actually increase the area of low WSS, as was shown in 
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this investigation. Numerous 2D and 3D studies have also found that increasing the axial 
distance between struts, effectively increasing the intrastrut area, is hemodynamically 
advantageous, as it allows for a greater area of flow reattachment between the struts [16, 
40, 60]. In the current results this trend was also demonstrated among stent designs in 
vessels with the same diameter. For these models, the cost function decreased for designs 
with a greater intrastrut area, indicating a greater intrastrut area is hemodynamically 
advantageous.  
To prevent the optimization from converging on an infeasible design solution in 
which there is no flow obstruction (i.e. no stent) in the vessel, stent thickness and 
intrastrut area were kept constant in this investigation. Intuitively, decreasing stent 
thickness and increasing intrastrut area would increase TAWSS, but this may reduce the 
radial strength of the stent and subsequently inhibit the ability of a stent to maintain 
arterial patency. Because of the mechanical constraints of stent design, the optimal strut 
thickness and intrastrut area cannot be determined based solely on stent hemodynamics.  
3.4 Case Study 2: Identification of optimal coronary stent designs based on vessel 
caliber 
 Target vessel caliber is a known predictor of restenosis following percutaneous 
stent implantation for the treatment of coronary artery disease [26, 42]. Rates of 
restenosis are significantly higher in patients with small diameter vessels since even a 
small amount of neointimal growth can severely restrict blood flow and require 
revascularization. Even when DES are used to inhibit neointimal growth, rates of 
restenosis remain high in this difficult patient subset [21, 49]. Depending on the 
definition applied, treatment of small vessel lesions constitutes 35-67% of percutaneous 
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interventions [81]. In contrast, large coronary vessels can sustain a greater amount of 
neointimal growth before requiring revascularization, and the use of DES over BMS in 
vessels >3.5 mm in diameter may not even be necessary [104]. 
Currently stent designs are often altered based on the vessel diameter in which the 
stent is deployed. While the underlying pattern of the stent design is not changed, the 
number of circumferentially repeating crowns or crests (NC) is increased for vessels of a 
larger caliber and vice versa. For larger vessels, the increase in NC provides more 
scaffolding and allows the stent to be expanded to a greater diameter. As demonstrated by 
the previous case study, increasing NC with increasing vessel diameter may also be 
hemodynamically advantageous.  
Building on the work of the previous case study (Section 3.3), the objective of the 
current investigation was to further analyze how vessel diameter affects the 
hemodynamically optimal stent configuration for both a generic slotted-tube stent along 
with three commercially available stents. In contrast to the previous case study, this 
investigation reframes the optimization problem in a manner that enables the relationship 
between vessel diameter and the optimal stent design stent to be examined in more detail 
than using discrete vessel diameters. Previously the vessel diameter and intrastrut area 
were kept constant and the optimal stent configuration was computed for vessel diameters 
of 2.25 mm and 3.0 mm. In this investigation, the stent configuration is kept constant and 
the optimal vessel diameter is computed. With this approach the expanded stent geometry 
is approximated for any diameter vessel in a manner that mimics the realistic expansion 
of a stent. Interestingly, this reframing of the optimization problem causes both the 
intrastrut area and intrastrut angle to vary for vessels of differing diameters. As a stent 
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expands the angle of the struts becomes more misaligned with the primary direction of 
flow resulting in localized areas of low WSS adjacent to misaligned struts. This suggests 
increasing NC may be hemodynamically advantageous as it would reduce the degree of 
strut misalignment. In contrast, reducing NC generally increases the intrastrut area of the 
expanded stent, allowing for a greater area of flow reattachment and higher WSS between 
stent struts. It is therefore hypothesized that there exists a hemodynamically optimal stent 
configuration in which the competing effects of strut misalignment and increasing 
intrastrut area are balanced. 
3.4.1 Stent and vessel model construction 
The designs of a generic slotted-tube stent (Figure 3.9, Stent A) along with three 
designs that resemble commercially available stents (Figure 3.9, Stents B-D) were 
investigated. Stents B and C were based on the BX Velocity (Cordis, Bridgewater, NJ) 
and Express2 (Boston Scientific, Natick, MA) stents respectively. Stent D was not based 
on any single stent design, but rather represents a simplified version of the Multi-Link 
family of stents (Abbott Vascular, Redwood City, CA), which includes the Vision, Mini 
Vision, Ultra and Zeta. The chosen stents geometries correspond to peak-to-peak (A and 
B), peak-to-valley (D), and hybrid (C) designs. 
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Figure 3.9: The geometry of a single cell with related dimensions along with an 
expanded configuration for each of the stent designs. All of the dimensions of the stent 
cells are given in millimeters. Each of the expanded stents shown has a diameter of 3.3 
mm. Stents A, B, and C are shown with a six crown configuration whereas stent D is 
shown with five crown configuration that incorporates both the two and three crown cell 
geometries. 
The geometry of a single cell of each design is illustrated in Figure 3.9 along with 
the dimensions relevant for approximating the expanded geometry of the stent, including 
the strut length (ls), arc length (la) and connector length (lc). The dimensions of stents B, 
C and D were based on product literature distributed by the manufactures. When 
generating a stent model, parameter d was computed based on vessel diameter and NC. 
Although the intrastrut angle (θ) is shown in Figure 3.9, it was not used to define the cell 
geometry. Rather the intrastrut angle was used extensively to quantify the results of the 
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optimizations as it provides a design independent measurement of the expanded stent 
geometry. The strut radial thickness and width for each design is given in Table 3.2. All 
stents were modeled using the 18 mm version of the stent, with the exception of Stent C 
which was modeled as 16 mm since an 18 mm Express2 stent is not available.  
Table 3.2: Strut dimensions for each of the stent designs in Figure 3.9. 
 Macro Struts Micro (or link) Struts 
Stent 
Design 
 Radial 
Thickness (µm) Width (µm) 
 Radial 
Thickness (µm) Width (µm) 
A 100 100 — — 
B 140 143 140 60 
C 132 91 132 61 
D 81 100 — — 
In the case of stents A, B and C, the number of circumferential repeating cells was 
simply varied to generate models with different values of NC. It should be noted that NC 
refers to the number of circumferentially repeating crowns, not the number of repeating 
cells (e.g. Stent C, NC=6 corresponds to 3 circumferentially repeating cells). Because the 
commercial versions of stent D contain both two and three crown cell geometries, 
permutations of stent D were allowed to incorporate both cell geometries into a single 
model. To distinguish between the various permutations, designs of stent D are referred 
to by the number of crowns and the cells used to create the design. For example, 6-3:3 
and 6-2:2:2 both refer to six crown designs but constructed with different permutations of 
cells. 
During the optimization of a single stent design, the stent configuration (i.e. NC) 
was kept constant and the expanded geometry of the stent was modeled for the vessel 
diameters chosen by the optimization routine. The expanded geometry was approximated 
by constraining the strut and arc lengths to be constant. This enabled quick generation of 
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stent models using SolidWorks. For stent design B, which incorporated a flexible link, it 
was assumed that the link maintained its shape across all diameters. 
Since the vessel diameter was allowed to vary during the optimization routine, a 
separate vessel model was generated for each stent model. The solid model of each vessel 
was constructed after the stent model was generated such that the expanded portion of the 
vessel could be modeled to the exact length of the expanded stent. In this manner the 
effects of stent foreshortening would also be incorporated in to the model (Figure 3.10). 
 
Figure 3.10: Illustrations of the expanded geometry of single stent cell (left) that was 
used to generate the three representative solids models of an idealized stented coronary 
(right). The vessel diameter depicted above each model corresponds to stent diameters of 
2.2 mm, 3.85 mm and 5.5 mm. The six crown configuration of Stent B is depicted in each 
model. 
3.4.2 Computational simulation and optimization methods 
 In the previous case study of slotted-tube stents, the greatest CFD mesh density 
was simply assigned to the stent cells in the middle of the stented region of the model. 
The middle stent cells were more difficult to define for the more elaborate designs of the 
commercial stents. For this case study, the middle stent cells were consistently 
determined by placing a plane through the middle of the vessel perpendicular to the 
direction of blood flow. Then the greatest mesh density was assigned only to intrastrut 
cells that intersected this plane (Figure 3.11). These cells also represent the surface over 
71 
 
which 𝑇𝐴𝑊𝑆𝑆����������𝐼𝑆 was computed. Depending on the stent model and vessel diameter, this 
meshing technique resulted in mesh sizes between 2.5 and 7 million elements. 
 
Figure 3.11: (Left) Anisotropic CFD meshes for stent designs A, B, C and D. (Right) 
TAWSS depicts on the stent cells are extracted and quantified during the optimization 
routine. TAWSS is shown normalized to the analytically computed value of TAWSS in 
an unstented portion of the vessel. 
 
To determine the optimal vessel diameter for a given stent configuration, a one-
dimensional parameter mesh was constructed for a range of vessel diameters between 2.0 
and 5.0 mm with an initial spacing of 0.5 mm. Over the course of the optimization, the 
parameter mesh was refined three times resulting in a final parameter mesh resolution of 
0.03125 mm. 
3.4.3 Results 
Some optimizations converged to the boundary of the allowable vessel diameter 
range (Table 3.3). Only 6-7 function evaluations were necessary in these cases, 
corresponding to the three vessel diameters of the initial set of design points and the three 
mesh refinements necessary to provide convergence to the boundary. In cases where the 
optimization did not converge to a boundary of the allowable vessel diameter range, the 
optimization routine required 9-18 function evaluations regardless of stent design. Each 
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optimization required four to seven days to complete depending on the number of 
function evaluations required. 
The optimal vessel diameter was identified for four stent designs in various 
configurations (i.e. different values of NC) for a total of 21 optimizations. The results of 
each optimization are summarized in Table 3.3. As expected, the hemodynamically 
optimal vessel diameter increased as NC increased for all stent designs (e.g. A NC =6, 
Ø=2.63 mm vs NC=7, Ø=3.13 mm). For designs A, B and C, the cost of the optimal 
design also increased with increasing vessel diameter (e.g. A NC=6, J=0.526 vs NC=7, 
J=0.535). This trend is less apparent for stent D, in which the optimal cost did not 
increase between the 4-2:2 and 5-2:3 designs or 6-2:2:2 and 7-2:2:3 designs.  
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Table 3.3: Optimal design cost and model parameters for each stent configuration. 
Circumferential 
Repetitions (NC) Cost 
Vessel Diameter 
(mm) 
Intrastrut 
Angle (°) 
Number of Function 
Evaluations 
Stent A     
5* 0.511 2.00 44.59 7  
6 0.526 2.63 50.74 11 
7 0.535 3.13 52.22 12 
8 0.542 3.75 55.97 10 
9 0.548 4.22 55.97 18 
10 0.552 4.81 58.09 15 
     
Stent B     
4* 0.538 2.00 61.42 6 
5 0.560 2.66 68.12 15 
6 0.572 3.50 79.96 9 
7 0.581 4.00 77.17 9 
8 0.587 4.75 82.45 9 
     
Stent C     
4 0.582 2.09 47.13 10 
6 0.611 3.88 66.69 12 
8* 0.625 5.00 63.22 7 
     
Stent D     
4 – 2:2 0.529 2.38 87.09 10 
5 – 2:3 0.529 3.13 96.88 11 
6 – 2:2:2 0.536 4.06 111.09 15 
6 – 3:3 0.530 3.88 104.00 11 
7 – 2:2:3 0.536 4.63 107.04 11 
8 – 2:3:3* 0.537 5.00 97.25 7 
9 – 3:3:3* 0.544 5.00 79.68 7 
* Optimization converged to the boundary of the parameter space 
The intrastrut area as a function of d (i.e. cell expansion curve) for a single stent 
cell is plotted in Figure 3.12. For the peak-to-peak stent designs (A and B), the cell 
expansion curve represents a concave function. This relationship is linear for the peak-to-
valley design (D). As a hybrid of peak-to-peak and peak-to-valley designs, the cell 
expansion curve for stent C is fairly linear with a small degree of concavity. The degree 
of expansion for each of the optimal models is also denoted in Figure 3.12. The optimal 
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intrastrut angle is generally smaller for designs A, B and C (A: 50-58°, B: 68-82°, C: 47-
67°) than that of design D (87-107°). 
 
Figure 3.12: The intrastrut area relative to the parameter d (expansion curve) for a single 
cell of each stent design. For stent D, the expansion curves of both the two crown (2c) 
and three crown (3c) cells are shown. The value of d corresponding to the cell geometry 
of each optimal model is denoted along the curve as a black dot. Only configurations in 
which the optimization did not converge to a boundary are plotted. As an additional 
reference, the intrastrut angle is also denoted above the x-axis. 
Plots of the design cost relative to the vessel diameter are shown in Figure 3.13. 
These plots can be used to identify the optimal stent configuration for any given vessel 
diameter. The optimal configuration is simply the curve with the minimum cost for a 
given vessel diameter. Similarly, an optimal vessel diameter range for each stent 
configuration can be estimated from the intersection of the cost function with adjacent 
stent configuration. For example, the cost curves for the NC=5 and NC=6 configurations 
of design A intersect at about 2.6 mm and the curves for the NC=6 and NC=7 
configuration of design A intersect at about 3.2 mm. Thus, the optimal vessel diameter 
range for the NC=6 configuration of design A is between 2.6 and 3.2 mm. The optimal 
vessel diameter ranges for each stent design is denoted by the alternating white and gray 
boxes on Figure 3.13. The 6-2:2:2, not the 6-3:3, stent design was used when computing 
the optimal vessel diameter range for stent design D, as this is representative of the six 
crown version of the commercially available Multi-Link Vision stent.  
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Figure 3.13: Cost function versus the vessel diameter for the various configurations of 
each stent design. The stent configuration, or number of circumferential crowns, is 
denoted above each curve. The model corresponding to the optimal vessel diameter is 
circled for each stent configuration. The optimal vessel diameter range for each 
configuration is denoted by the alternating gray and white shaded areas. Both the 3:3 and 
2:2:2 configurations of stent D represent a six crown stent, but the optimal vessel 
diameter range was not computed for the 3:3 configuration so it is denoted with a dotted 
line. 
Using a similar analysis, a comparison of the hemodynamic performance among 
the various stent designs is shown in Figure 3.14 by plotting a least cost curve for each 
design. The least cost curve is constructed by extracting the minimum possible cost from 
among all the configurations of a stent design for entire vessel diameter range as plotted 
Figure 3.14. A comparison of the least cost curves indicates that in the most 
hemodynamically favorable configuration, stent design C performs worse than all other 
stent designs regardless of vessel diameter. Stent D is the best performing commercially 
inspired stent design, while the generic slotted-tube stent is the best performing design in 
vessels less than 3.0 mm in diameter. 
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Figure 3.14: Comparison of the least cost curves of each stent design. The least cost 
curve represents the most best hemodynamic cost of a stent design for all vessel 
diameters between 2.0 and 5.0 mm in diameter. 
Histograms of the normalized TAWSS over the intrastrut area for each optimal 
model are shown in Figure 3.15. Each histogram was constructed with a bin size of 
normalized TAWSS equal to 0.02. For a given stent design, the histograms of normalized 
TAWSS are similar for the optimal models among all configurations, thus the pattern of 
TAWSS is only shown for one representative stent cell. The histograms of stent designs 
B and C are more skewed towards lower values of TAWSS when compared to designs A 
and D, indicating a greatest area of low TAWSS is generated by the optimal models for 
these stent designs. Visual inspection of the TAWSS over the stent cell of design B 
illustrates a majority of the low TAWSS is localized near the connector element (Figure 
3.15, Stent B dotted line). Similarly, the design of stent C produces localized areas of 
decreased TAWSS near connector elements as well as in the middle of the intrastrut area 
(Figure 3.15, Stent C dotted lines). 
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Figure 3.15: Histogram of the TAWSS over the intrastrut area of optimal stent models 
along with a representative pattern of TAWSS on an optimal stent geometry. Histograms 
are only plotted for optimizations that did not converge to a boundary. TAWSS is shown 
normalized to the TAWSS computed in the unstented portion of the vessel. Localized 
areas of low TAWSS near cell connector elements are indicated by the dotted lines for 
stents B and C. 
 Given that the designs of stents B, C and D closely resemble the commercially 
available BX Velocity, Express2 and Multi-Link stents respectively, a comparison of 
hemodynamically optimal vessel diameter range (Figure 3.13) to that of the 
manufacturer’s recommended diameter range is presented in Table 3.4. The expanded 
geometry of a single stent crown at the minimum and maximum of each range is also 
depicted in Figure 3.16. For any given vessel diameter, the commercial stents are 
configured with a greater number of crowns than the hemodynamically optimal 
configurations. 
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Table 3.4: Comparison of the vessel diameter range recommended by stent manufactures 
and the hemodynamically optimal vessel diameter range predicted by the CFD 
simulations in this investigation. 
 Diameter Range (mm) Intrastrut Angle Range (°) 
Circumferential 
Repetitions (NC) Manufacturer 
Simulation 
Based Manufacturer* 
Simulation 
Based 
(N/A)/A     
5  – 2.58  – 65.4 
6  2.58 – 3.22  50.6 – 67.4 
7  3.22 – 3.75  54.3 – 67.4 
8  3.75 – 4.34  55.9 – 68.4 
9  4.34 – 4.82  58.0 – 68.1 
10  4.83 –   58.7 – 
     
BX Velocity/B     
4  – 2.55  – 93.4 
5  2.55 – 3.28  63.5 – 97.4 
6 2.25 – 3.00  3.28 – 3.98 36.6 – 61.4 70.8 – 100.4 
7 3.00 – 3.50 3.98 – 4.59 46.9 – 61.4 76.3 – 99.5 
8  4.59 –  78.5 – 
     
Express2/C     
4  – 3.24  – 85.6 
6 2.25 – 3.50  3.24 – 4.98 20.4 – 48.2 43.7 – 86.3 
8 4.00 – 5.00 4.98 – 36.8 – 54.1 53.7 – 
     
Multi-Link/D     
4 – 2:2  – 2.71  – 103.7 
5 – 2:3  2.71 – 3.75  71.5 – 130.6 
6 – 2:2:2 2.00 – 3.00  3.75 – 4.33 29.6 – 61.7 89.8 – 117.7 
7 – 2:2:3  4.33 –  89.1 – 
8 – 2:3:3     
9 – 3:3:3† 3.50 – 5.00   41.4 – 75.4  
* Manufacture’s intrastrut angle was computed using the designs of stents B, C and D 
† Manufacture’s diameter range based on combination of Multi-Link Vision and Ultra 
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Figure 3.16:  Comparison of the vessel diameter range of each commercially available 
stents to the hemodynamically optimal diameter configuration diameter range. The 
expanded geometry of a single circumferential crown corresponding to the minimum and 
maximum cell expansion of each range is also shown. 
3.4.4 Discussion 
This case study used the stent optimization method to identify the 
hemodynamically optimal vessel diameter for various configurations of a generic slotted-
tube and three commercially available stent designs. The results indicate that current 
commercial stent configurations have a greater number of circumferentially repeating 
stent crowns than is hemodynamically optimal. Presumably a larger number of stent 
crowns provide a greater amount of vessel scaffolding, but the current results 
demonstrate that this also increases the area of the vessel exposed to potentially 
deleterious levels low TAWSS.  
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The unique framing of the optimization problem in this case study facilitated a 
thorough and detailed analysis of the relationship between vessel diameter and stent 
configuration without necessitating numerous optimizations. The main objective of the 
investigation was to identify the optimal value of NC for a given stent design and vessel 
diameter. This naturally implies formulating the optimization problem to directly solve 
for the optimal value of NC while maintaining vessel diameter constant. Instead this 
investigation used the reverse formulation to identify the optimal vessel diameter for a 
given NC. This approach did not directly solve for NC, but rather indirectly computed the 
optimal value of NC for a given stent design and vessel diameter by examining the 
relationships between the cost function and vessel diameter (Figure 3.13). Moreover, the 
reverse formulation also enabled the analysis of the optimal intrastrut angle and quick 
computation of the optimal vessel diameter range for each stent configuration. The direct 
approach would require numerous optimizations to compute these parameters with the 
same accuracy achieved using the reverse formulation. 
The results of this investigation confirm and extend the findings of the previous 
case study (Section 3.3) in which it was determined that the optimal value of NC 
depended on the intrastrut angle for a generic slotted-tube stent, similar to stent A. As 
shown by the intrastrut angles of the optimal models (Table 3.3), the small range of 
optimal angles for each stent design supports the previous conclusion that the optimal 
value of NC is dependent on the intrastrut angle. However, contrary to the findings of the 
previous study, the current results indicate that the optimal intrastrut angle is somewhat 
dependent on vessel size. The optimization routine generally converged to designs with a 
smaller intrastrut angle in small diameter vessels (Table 3.3). The discrepancy between 
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the findings of these studies is likely caused by the difference in design constraints used 
in each study. In the previous study, the intrastrut area was constrained to 1 mm2, 2 mm2 
or 3 mm2 and optimization were only performed with 2.25 mm and 3.0 mm diameter 
vessels. The current results were obtained by constraining the stent strut dimensions and 
allowing the vessel diameter, and subsequently the intrastrut area, to vary. These 
constraints mimic the realistic deployment of a stent and result in a better approximation 
of the optimal intrastrut angle. Thus the optimal intrastrut angle for a slotted-tube design 
is likely between 50° and 60°, as opposed to the previously reported value of 40°. 
There was a large difference in the optimal intrastrut angle observed between 
various stent designs. The optimal intrastrut angle for peak-to-peak (A and B) and hybrid 
(C) designs was smaller than that of the peak-to-valley design (D). Based on the 
hypothesis that the optimal stent design represents a balance between progressive strut 
misalignment and increasing intrastrut area, this finding is likely explained by the 
nonlinear relationship between the intrastrut area and the vessel diameter for stent designs 
A, B and C (Figure 3.12). Unlike the linear relationship of peak-to-valley designs, the 
rate of increase in intrastrut area decreases with increasing stent diameter for peak-to-
peak and hybrid designs, resulting in a smaller optimal intrastrut angle. This is most 
evident for designs A and B, in which the cell geometry of each optimal model 
corresponds to a similar location on the cell expansion curve slightly less than the 
possible maximum cell area. 
The present findings indicate the cost of the models corresponding to the optimal 
vessel diameter of a given stent configuration increases with increasing vessel diameter 
and NC for designs A, B and C. This relationship causes the value of the optimal vessel 
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diameter to be skewed towards the low end, or fall completely outside of the optimal 
vessel diameter range for most configurations (Figure 3.13). For example, the optimal 
vessel diameter for the NC=7 configuration of design B is 4.00 mm, while the optimal 
vessel diameter range of this configuration is about 4.00-4.60 mm. The lack of this trend 
in stent D likely arises from the combined use of two and three crest cell geometries. 
Incorporating a three cell geometry into the stent configuration generally resulted in 
lower costs than the two crest cell design as evident by comparison of the 6-2:2:2 and 6-
3:3 optimization (Figure 3.13). Although the two stent designs have the same number of 
crowns, the 6-3:3 stent has a lower associated cost (0.536 vs. 0.530). 
The least cost curves (Figure 3.14) and TAWSS distributions (Figure 3.15) both 
suggest that the relative ranking of performance (best to worst) of the commercially 
inspired stent designs considered is D (Multi-Link), B (BX Velocity) and C (Express2). It 
should be noted that some commercial versions of Stent D include a flexible connector 
link that would likely produced a greater area of low TAWSS than was computed here 
which may affect this ranking. While these rankings provide insight to relative 
performance of commercial stents, they cannot be used to draw any general conclusions 
about the performance of peak-to-peak, peak-to-valley or hybrid designs as the strut 
thickness and width was selected among the stent designs to mimic the dimensions of the 
commercially available equivalents. This investigation also highlights the superior 
adaptability of the peak-to-peak and peak-to-valley designs to various vessel diameters as 
compared to the hybrid design (Figure 3.16). The number of circumferential crowns of 
the hybrid design can only be incremented by a factor of two due to the cell geometry, 
whereas the other designs allow for unit increments. 
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Compared to configurations of commercially available stents, the current results 
suggest that hemodynamically optimal stents contain fewer circumferentially repeating 
crowns, which results in greater spacing between struts. While an increase in strut 
spacing is hemodynamically advantageous, this may adversely affect other stent design 
criteria. Specifically, increasing strut spacing imposes higher focal mechanical stresses on 
the artery and may reduce the radial strength of the stent [10]. For DES stents, increased 
strut spacing reduces the uniformity of drug release along with the intrastrut drug 
concentration [45]. Interestingly, a previous study by Iakovou et al. demonstrated that 
increased strut spacing was not associated with unfavorable clinical outcomes for the 
Cypher stent, the DES version of the BX Velocity [31, 35, 88, 93, 100]. In this study six 
crown Cypher stents were overdilated beyond the suggested 3.0 mm diameter maximum 
for 3.5-4.0 diameter vessels, similar to the hemodynamically optimal vessel range for this 
stent configuration. Overdilation was not associated with increased late lumen loss or 
binary restenosis rate. However, this study was only performed in large diameter vessels 
which are generally associated with a decreased rate of restenosis and is unclear if these 
results would translate to smaller vessels. Similarly, overexpansion of the Express2 and 
Multi-Link designs has not been studied in detail. 
3.5 Discussion of the optimization methods 
3.5.1 Summary 
Stent design and geometry are known to influence clinical outcomes including 
endothelialization and restenosis after DES and BMS implantation, respectively [11, 40, 
60-62], but previous studies have largely employed a “trial-and-error” approach to 
improving stent design. This works represents the first investigation to use a 
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computationally efficient method for optimizing cardiovascular stent design in unsteady 
flow using CFD.  
The cost function used in the optimization routine measured the disparity in 
TAWSS between the stented region and unstented region. While this cost function is 
representative of the well-establish concept of WSS homeostasis, the actual value of this 
index has not previously been studied or correlated to vascular disease. Other CFD 
studies have used a critical value of 4 or 5 dynes/cm2 as the threshold of low WSS [54], 
as it has been correlated to intimal thickening [39, 66, 70, 86]. However, using a 
threshold may not be able to differentiate between device designs in flow environments 
with excessively high or low WSS. The cost function used in this investigation is more 
versatile than a thresholding cost function and capable of discriminating between stent 
designs regardless of flow environment, which was most evident in Case Study 2. The 
magnitude of WSS varied greatly among these models since the inflow rate was kept 
constant for a wide range of vessel diameters. Because the TAWSS in the stented region 
of the model was normalized to TAWSS in an unstented region of the vessel, the 
formulation of the cost function was not dependent of vessel diameter. 
In the current investigation, only the magnitude of TAWSS was considered as a 
determinant of the optimal stent design. Although low TAWSS is the most commonly 
studied index for predicting in-stent restenosis, several researchers postulate that 
oscillatory shear index, spatial or temporal wall shear-stress gradients, and wall shear 
stress angle gradients may also be useful indices for predicting restenosis [8]. The current 
optimization methodology could be adapted to perform multi-objective optimization 
[119] in order to include the effects of other hemodynamic indices in future studies. For 
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example, Yang et al. recently implemented multi-objective optimization with regard to 
energy efficiency and WSS to determine the optimal a shape for a Fontan surgical design 
which is performed on patients with single ventricle heart defects [57]. 
3.5.2 Limitations 
The present results should be interpreted within the constraints of several 
potential limitations. Each coronary vessel was modeled as an ideal cylinder which likely 
does not represent the actual vessel geometry following stent deployment. As discussed 
earlier (Section 2.1), a finite element simulation of the stent expansion may be the best 
method for determining the expanded geometry of the stent and vessel, but this approach 
would further increase the computational cost of the already computationally expensive 
optimization routine and therefore was not pursued in this investigation. Though the 
previously described patient-specific model of a coronary bifurcation employed a 
deformable wall model (Section 2.4.1), the vessel models in this investigation employed 
a rigid wall assumption for all CFD simulations for simplicity and increased 
computational efficiency. Since the compliance of stented arteries has been shown to be 
nearly zero, a rigid wall assumption is likely valid within the stented region that is 
quantified during the optimization routine [95, 96].  
The current optimization method does not consider uncertainty in simulation or 
model inputs (i.e. model inflow waveform, boundary conditions, blood rheology, stent-
to-artery ratio, etc.) that may affect the optimization output. As an example, the influence 
of the inflow waveform was analyzed by recomputing the optimal diameter of stent 
design A with NC=6 using a steady inflow instead of a pulsatile waveform. The 
optimization converged to the same vessel diameter for both inlet boundary conditions, 
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but the cost was lower for the steady inflow condition when comparing models of equal 
vessel diameter (Figure 3.17). This analysis suggests the design cost is sensitive to the 
contour of the inflow waveform, but the inflow does not affect the optimal design 
parameters. Unfortunately it is tough to elicit a definitive relationship between the inflow 
and cost since only two inflow cases were examined. It is also unknown if the 
relationship between the inflow and cost would be similar for all of the stent designs and 
the entire range of vessel diameters studied here. These potential differences in the cost 
due to the inflow may affect the computed optimal vessel diameters (Figure 3.13) and 
relatively ranking of the stent designs (Figure 3.14). Thus, each of the optimizations in 
this investigation used a pulsatile inflow similar to a human coronary waveform for 
increased physiologic realism and to reduce the potential influence of a steady inflow. 
This analysis of the model inflow underscores the difficulty in understanding the 
potential influence of possible input variables. Future studies that implement robust 
optimization techniques may provide a better understanding of the sensitivity of output 
parameters to input uncertainties [19].  
 
Figure 3.17: The cost function versus the vessel diameter for the stent B (NC=6) when a 
steady and a pulsatile inflow is applied to the CFD model. The model corresponding to 
the optimal vessel diameter is circles on each plot. 
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In the first part of this thesis (Chapter 2), the computational mesh of each stented 
model was scrutinized to ensure mesh independence by comparing WSS between 
successive meshes with increasing mesh densities. This analysis was not included in the 
optimization routine since it usually required three to five mesh refinements to reach 
mesh independence, and the process of successive mesh refinements would drastically 
increase the computational expense of the optimization routine. Instead mesh 
independence was investigated by computing the optimal vessel diameter of stent design 
B with NC=5 using two different mesh densities. The anisotropic mesh generation 
parameters were tailored to create meshes with roughly 3-4 and 6-8 million elements for 
this stent configuration. The optimization converged to a vessel diameter of 2.625 mm 
when high density meshes were used compared to 2.65625 mm for the low density 
meshes (Figure 3.18). In general, the cost of stented models was slightly increased for 
models with a higher mesh density, but the relative difference in cost was <1% between 
models with an equal vessel diameter. Since doubling the mesh size only resulted in 
small variations in the computed cost and the optimal vessel diameter, the optimization 
results were assumed to be independent of the computational mesh for the relatively low 
density meshes. The meshing parameters used to generate 3-4 million element meshes 
were used throughout the entire investigation.  
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Figure 3.18: The cost function versus the vessel diameter for the stent B (NC =5) for 
computational meshes with a density of 3-4 million elements (1x) and 6-8 million 
elements (2x). 
This work attempted to include some of the most widely used stents geometries at 
this time. The companies referred to here may now have, or be developing, newer stents 
for which the demonstrated optimization techniques could be used to identify the 
hemodynamically optimal designs configurations. The current results do describe some 
general hemodynamic characteristics of peak-to-peak, peak-to-valley stent and hybrid 
designs which are likely applicable to new designs without a complete optimization 
analysis. However, the variability among designs within these categories, as shown by 
the difference in optimal configurations of stents A and B (Table 3.3 and Figure 3.16), 
suggests a complete optimization analysis is necessary for each unique stent design. 
3.6 Conclusion 
In summary, the current investigation describes an efficient optimization 
framework that uses 3D CFD coupled with a derivative-free optimization routine to 
indentify hemodynamically optimal stents. The method was applied to analyze the 
optimal number of circumferentially repeating stents cells and intrastrut angle that 
minimize the area of low TAWSS for various stent designs. In general, the results 
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indicate that commercial stent designs incorporate a greater number of circumferentially 
repeating stent crowns than is hemodynamically optimal, which may subject the vessel to 
potential deleterious levels of low TAWSS and may partially explain why rates of 
restenosis remain high after stent implantation in small diameter vessels. Incorporating 
the results of this investigation in future stent designs may improve endothelialization 
after DES and reduce neointimal hyperplasia and subsequent restenosis after BMS.  
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Chapter 4 
  
Future Directions and Conclusion 
 
4.1 Future computational investigations 
The findings of the optimization case studies would be particularly interesting 
when coupled with additional solid mechanics, deliverability and drug-elution analyses 
often considered when designing a stent. In this investigation, the parsimonious choice of 
stent parameters ensured the optimization did not pursue infeasible stent designs. This 
resulted in only one stent or vessel parameter varying during each optimization, but the 
SMF optimization algorithm is fully capable of considering multiple design parameters 
[13, 64, 120]. Implementing a multi-objective optimization that considers additional, non-
hemodynamic design criteria would enable additional design parameters to be optimized. 
For example, optimizing the strut thickness from a purely hemodynamic perspective 
produces an optimal stent design with a negligible thickness. However, if the radial 
strength of the stent was also considered, the competing solid mechanic and 
hemodynamic effects of reducing strut thickness would prevent the optimization from 
converging on an infeasible design. Additional solid mechanics design criteria might  
also include the compliance and stress induced on the arterial wall which are known to be 
influenced by strut thickness and intrastrut area [9, 31]. In designing DES, smaller 
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intrastrut areas that promote uniform drug distribution are favorable since non-uniform 
drug concentrations resulting from stent geometry or overlapping stents have previously 
been shown to suppress re-endothialization atop stent struts [8, 119]. As discussed earlier, 
the SMF optimization technique can be adapted to perform multi-objective optimization 
[92], which would enable a thorough analysis of the trade-offs between hemodynamic 
indices the other design criteria. Therefore the largest obstacle to considering additional 
design criteria within the optimization routine is incorporating additional numerical 
analyses, such as FEA or drug advection-diffusion, into the optimization framework. 
 The optimization methodology presented here was developed to understand the 
relationship between stent configuration and vessel diameter, and possibly improve stent 
design for treating small vessel lesions. With a few modifications, this methodology 
could be used to investigate potential design improvements for treating other difficult 
lesions subsets such as those in the left main coronary artery where efficacy data for most 
stents is limited and local disruptions in the vicinity of the bifurcation increases the 
potential for flow patterns linked neointimal growth and thrombus formation [58]. 
Additionally, the optimization method could be coupled with the patient-specific stenting 
method (Chapter 2) to determine the optimal stent designs for individual patients. 
Determining the optimal geometry of the flow diverting cerebral stent (Section 2.5) 
would be a particularly interesting application for the optimization method. 
4.2 Validation of optimization results with animal models  
 The application of the stent optimization method generally indicate that 
decreasing the number of circumferentially repeating stent crowns of commercially 
available stent designs would subsequently reduce neointimal growth and promote the 
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endothelialization of strut.  To be clinical relevant, this finding needs to be validated with 
an animal model. LaDisa et al. developed a technique for implanting stents in rabbit iliac 
arteries [63], which was later used to correlate low WSS with increased neointimal 
hyperplasia . Using the computed optimal vessel diameter range for various stent 
configurations (Figure 3.16) as a guide, the stent implantation method could be used to 
implant stents with the optimal, less than optimal and greater than optimal number of 
circumferential repeating stent crowns depending on the measured diameter of the rabbit 
artery. The rabbits would then be euthanized after 21-28 days to quantify the amount 
neointimal hyperplasia within each experimental group, thereby validating the results of 
the CFD based optimization. With the addition of medical imaging, the subject-specific 
stenting methods could be also used to generate a model of the flow domain for each 
rabbit following stent implantation. 
4.3 Conclusion  
 The computational techniques for evaluating cardiovascular stent designs 
described in this thesis constitute a substantial improvement over previous CFD studies 
of stent design. Previous studies have largely relied on simple vessel and stent geometries 
to described hemodynamic alterations in response to coronary stent implantation. 
Therefore, the method of virtually implanting commercial stents into patient-specific 
vessel geometries (Chapter 2) represents a necessary advancement in stent modeling 
techniques to further understand hemodynamics in complex coronary lesions geometries 
(e.g. bifurcation lesions) that remain difficult to treat and to evaluate emerging 
applications of stent implantation (e.g. flow-diverting stents). To the author’s knowledge 
this is also the first investigation to couple an optimization algorithm 3D CFD to 
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determine hemodynamically optimal stent designs (Chapter 3). Collectively, these 
methods provide a means of systematically evaluating and improving the hemodynamic 
performance of current and next-generation stents. Moreover, these methods can be used 
to avoid the costly trial-and-error approach to stent design that has often been used in the 
past.   
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 COMPUTATIONAL MODELS AND SOURCE CODE 
The patient-specific stent models, code for advanced quantification methods and 
code implemented within the optimization framework is available by contacting Timothy 
Gundert at (920) 979-9673 or Dr. John F. LaDisa, PhD in the Department of Biomedical 
Engineering at Marquette University. 
